(1) eipo (2) (3) eipo (4) (5) - PDF Free Download

999,640,000667,540,000 332,100,000 99,964,000 899,676,000567,576,000 332,100,000 5.921%0.003% 0.005% 0.02 2186 32 342C 201472 2014775.925.38 5.921%0.003%0.005% 5.92 5.385.92 www.hkex.com.hkwww.luye.cn 201477 201479 S (i) 144A(ii)S 2014626

(1) www.eipo.com.hk eipo (2)...201472 1130 (3)...201472 1145...201472 12 eipo...201472 12 (4)...201472 12...201472 12 (5)...201472.................201478 www.hkexnews.hk www.luye.cn...201478 www.iporesults.com.hk...201478 i

(1) (6)(7)(8)............................ 201478...201478...201479 (1) (2) 1130www.eipo.com.hk 1130 12 (3) 201472912 201472 (4) (5) 201472201477 201477 5.92 5.921%0.005%0.003% (6) (i)(ii) 2014798 (7) ii

(1) (8) eipo1,000,000 20147891 183171712-1716 1,000,000 201472912 iii

... i... iv... 1... 11... 23... 38... 40... 72... 74... 78... 82... 84... 94... 114... 132... 204... 250... 257... 259... 262... 266... 268... 280... 283... 294... 302... I-1... II-1... III-1... IV-1... V-1... VI-1 iv

40 29 201120122013 92.2%85.9%83.6% MENET2013 2013 2013IMS MENET 2013 20132013 IMS MENET 2013IMS2013 2011201220131,577.6 1,864.62,215.188.9% 87.3%88.1%18.5% 1

201350 1,30050080030 8,000 2013123122 2020172018 MENET2008201320131231 26630124 2013123123084 7577 2011 2012 2

153.72013238.955.4% 20131231 20131231 30 18 2436201120122013 109.4129.1166.6 2011201220131.2 0.61.8 2011201220131,774.4 2,135.92,515.119.1%2011 20122013166.2175.6 327.940.5%201120122013 83.0%83.5%83.6% 3

(i) (ii) (iii)(iv) (v) (vi)(vii) (viii)(ix) (x)(xi)(xii) (xiii) (xiv) 40 1919 2011 201220131954.2% 55.4%56.0% 201120122013 44.3%43.4%43.0% 5

101 164 204 1231 2011 2012 2013 % % %... 1,774,390 100.0 2,135,943 100.0 2,515,111 100.0... (301,121) (17.0) (351,813) (16.5) (413,506) (16.4)... 1,473,269 83.0 1,784,130 83.5 2,101,605 83.6... 25,934 1.5 12,717 0.6 35,902 1.4... (980,111) (55.2) (1,209,717) (56.6) (1,378,061) (54.8)... (151,566) (8.5) (157,906) (7.4) (146,508) (5.8)... (147,307) (8.3) (145,522) (6.8) (206,669) (8.2)... (19,636) (1.1) (29,145) (1.4) (24,091) (1.0)... 545 0.0 894 0.0 990 0.0... 201,128 11.4 255,451 11.9 383,168 15.2... (34,902) (2.0) (79,862) (3.7) (55,224) (2.2)... 166,226 9.4 175,589 8.2 327,944 13.0 1231 2011 2012 2013... 932,041 1,088,568 1,652,370... 878,987 884,200 1,302,983... 53,054 204,368 349,387... 1,404,387 1,583,807 1,897,695 6

1231 2011 2012 2013 % % %... 584,160 32.9 699,912 32.8 847,155 33.7... 162,630 9.2 181,673 8.5 185,757 7.4... 34,072 1.9 36,891 1.7 43,330 1.7... 19,059 1.1 22,354 1.1 23,923 1.0... 799,921 45.1 940,830 44.1 1,102,165 43.8... 326,228 18.4 295,887 13.9 338,453 13.5... 244,131 13.8 285,859 13.4 333,532 13.3... 43,567 2.4 48,908 2.2 51,094 1.9.. 613,926 34.6 630,654 29.5 723,079 28.7... 34,621 1.9 153,653 7.1 238,919 9.4... 191,775 10.8 210,711 9.9 227,910 9.1... 53,642 3.1 86,722 4.1 108,408 4.4... 280,038 15.8 451,086 21.1 575,237 22.9... 80,505 4.5 113,373 5.3 114,630 4.6... 1,774,390 100.0 2,135,943 100.0 2,515,111 100.0 (1) 19952001 2003 20131231 201312312014331 741.4615.4 83.0%2014331 7

2014 331 376.5182.0122.1 20143312014331 2410 99,964,000 S 899,676,000 567,576,000 332,100,000 30.1% 34.6% 5.38 5.92 (1)... 17,867 19,661 (2)(3)... 1.511.21 1.621.30 (1) 3,321,073,843 (2) 3,321,073,843 5.385.92 (3) 20145 52,865,878324,339,0001.006.1351 51,932,992200,000,000 1.325.38 1.42 5.92 8

5.65 3,592 20%718 20%718 20%718 20%718 5%180 5%180 10%360 1,816.22,636.25.65 9

20145 52,865,878 1.00 6.1351324.3 5.65 144.0 37.62014 106.4 CDH FlowerCPE GreeneryBeyond Border 248,711,018.31 1,110,503,913CPE Greenery CPE Palm Beach L.P.267,902,223 CPE Palm Beach L.P.Tropical Excellence CDH Flower CPE GreeneryBeyond BorderTropical Excellence 6.4%6.8%5.4%5.9%121 45.4% Ginkgo Trust Limited70% 10

Apex Group Holdings Apex Group Holdings Limited1993610 200372 70%15% 15% 200372 BCC Research 19949 1 Beyond Border Beyond Border Investment Limited 2011 1017 Beyond BorderHarvest Hill Investment Ltd. AXA Direct Asia II, L.P. Beyond Border Beyond Border 11

BMI 2014619 A. 3. 12

CDH Flower CDH Flower Limited2012116 CDH FlowerCDH Pharmaceutical Investments Limited CDH Flower CDH Flower 32 綠葉製藥集團有限公司 200372 2012128 CPE Greenery CPE Greenery Ltd. 2012116 CPE Greenery CPEChina Fund, L.P.CPE Palm Beach L.P. CPE Greenery CPE Greenery 13

2007316 2007126 200811 248,711,018.31 CDH FlowerCPE GreeneryBeyond Border eipo 99,964,000 14

1%0.003% 0.005% 2014625 IMS IMS Health Incorporated 899,676,000567,576,000 332,100,000 S144A 15

Kang Hai Pharmaceutical Kang Hai Pharmaceutical Technology Development Limited2002622 2014617 201479 16

Ginkgo Trust Limited201458 Shorea LBG 201458 2011831 Luye Hong Kong Luye Pharma Hong Kong Limited20077 31 20071210 20071210 19931117 70% 15% 1997327 17

MENET 2002222 20133 OECD 1% 0.003%0.005% 18

30 149,946,000 15% 144A S S A. 3. 144A 144A 19

332,100,000 505(b)(2) 505(b)(2) Beyond BorderCDH FlowerCPE GreeneryTropical Excellence 571 199468 0.02 200012 21 Solid Success Solid Success Holdings Limited20028 22 20

Steward Cross Steward Cross Pte. Ltd.1996516 36% 149,946,000 20131231 Tropical Excellence Tropical Excellence Infrastructure Pte. Ltd. 1996112 GIC Special Investments Pte. Ltd.Tropical ExcellenceCPE Greenery 1933 eipo www.eipo.com.hk 21

eipo 2001416 90% 10% 22

100 25

100 100500 500 26

FDA 27

DNA G1S II 28

GMP GSP 2013122 ACE FDA 29

DNA 30

II 32

DNARNA 33

PCT 34

II 5060 37

201120122013 88.9%87.3%88.1% 20112012201365.1%60.0%60.4% 201120122013 32.9%32.8%33.7% 2011201212315.3644.734 19 20112012201319 54.2%55.4%56.0%7 201120122013 44.3%43.4%43.0% 40

201189 15%201120122013 15.7%20.6%22.8%20112012 3%20112012 2012519%2011 2012201310.8%9.9%9.1% 201120125% 201210 201120122013 1.9%1.7%1.7%2012 20133% 41

20086 36 20091 2008620091 43

FDA 44

201333.7%13.5% 2013123190.3%96.7% 46

10 47

20131231800 48

2013123123084 75773129 78 2019 2020 2021201120122013 57.8%56.4%56.1% 50

201120122013 7.6%6.3%7.7% 54

20131231 20131231 55

20131231 56

15% 25%201120122013 25.029.537.7 201120122013 30.438.449.5 2014 15%25% 201120122013 17.55.530.8 57

20131231347.410.3% 200638.42007 114.22009 22.32011 159.1 3 2.3 20131231 58

10 59

20131231745.3 724.420.0 3090 2011201220131231313.8 339.5393.5 57.955.853.2 61

19942001 2014324 262 21,4404% 2,779 2013123130 63

100,000 20137 64

20 1979 65

2005 200572013630% 10% 50% 10% 200811 66

25% 2009420117 25% 10% 10% 10% 67

2008829142 68

1.56 5.65 69

45.4% 70

8.12 8.12 (a) 3.05 (b) (c) (d) (e) 9.09(b) 2012128 72

41.9% CPE GreeneryCPE Palm Beach L.P. CPE Coinvest Management Limited 10.1% CPE Coinvest Management Limited Tropical ExcellenceCPE Palm Beach L.P. (i)(ii)cpe GreeneryTropical Excellence 9.09(b) (a) (b) (c) (d) CPE GreeneryCPEChina Fund, L.P.CPE Palm Beach L.P. Tropical ExcellenceCPE Greenery CPE Palm Beach L.P. CPE GreeneryTropical Excellence (i) (ii) 73

44B(1) D.10. 201479500 2186 75

Codan Services Limited 76

1.000.8010 1.006.2090 1.007.7515 H.10 20146131.006.1977 77

78 198 98 5#09-08 1 W39 45 12401 89 846E 5057 1801 16 291014

79 12 2 52 16C 2 16A 38 15B 8 52 3 50 88 18 8 42

3 50 1 26 8 52 3 50 1 26 1 22 1 11 80

7 A40 Conyers Dill & Pearman 8 2901 15 23 580 45-46 1 81

Clarendon House 2 Church Street Hamilton HM 11 Bermuda 9 264003 2272 3D 200336 15 8 www.luye.cn (FCISFCS) 15 8 1 W39 45 12401 82

181 27 183 171712-1716 Codan Services Limited Clarendon House 2 Church Street Hamilton HM11 Bermuda 139 125 128 2 1-2 83

2008315,9702012529,240 13.8%201212.0%Economist Intelligence Unit EIU2013581,550 2017858,25010.2% EIU20082012 23,95639,34913.2% 201343,0782017 62,6009.8% 100,000 80,000 60,000 40,000 20,000 31,597 71,246 64,407 58,155 52,924 47,262 40,282 34,878 35,296 30,196 23,956 26,323 52,348 47,498 43,078 39,349 78,400 85,825 57,394 62,600 80,000 60,000 40,000 20,000 0 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 0 EIU 84

EIU20081,426 20122,65416.8% 20133,02120174,82612.4% EIU 200613.1201213.5 EIU6520067.9%104.2 20129.4%127.1 EIU 20122012 2012 3,500 2,908 3,000 2,500 2,000 1,500 1,000 500 566 448 403 316 236 207 203 183 174 0 EIU OECDEspicom 2008201219.9% 2012333 85

2012 2008 2012 20082012 (%)... 2,907.8 7,980 9,262 3.8... 566.3 3,238 4,491 8.5... 447.9 161 333 19.9... 402.6 4,739 4,930 1.0... 316.0 5,107 4,942 (0.8)... 235.6 3,970 3,732 (1.5)... 206.7 4,769 5,927 5.6... 202.7 735 1,041 9.1... 183.2 3,404 3,010 (3.0)... 174.1 5,058 7,598 10.7 OECDEspicomEIU OECDEspicom2012 5.3%12.0%17.9% 2012 2012 (%) 20.0 17.9 16.0 12.0 9.0 9.1 9.5 9.5 9.5 11.4 11.7 12.0 8.0 5.0 5.3 5.3 4.0 0.0 OECDEspicom EIU 20082,13020124,480 20.5% 20132017 13.6%20178,470 86

87 213 264 308 386 448 509 589 668 768 847 0 100 200 300 400 500 600 700 800 900 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 EIU 200810 2009317 (2009-2011) 2013320092012 22,4276,555 20092011 8,500 20128 2020 20202020 2020 771.3% 0.02%

6.5%7.0% 2020 2020 201310 2020 8.0 1.3 Business Monitor International 43(CNS) 20094 (ADHD)5%69 50 2012 88

201210 2012 (1/100,000) (1/100,000).... 164.5.... 151.5.... 131.6.... 135.9.... 120.3.... 119.5... 75.6... 103.9... 34.8... 58.9... 17.3... 16.8... 15.2... 10.7... 6.9... 6.6... 6.3... 6.3.... 23.8.... 29.3 Espicom2008 345201269719.3%Espicom 20171,6602013201718.8% 180 160 140 120 100 80 60 40 20 34 Espicom 0 42 48 58 70 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 83 99 117 139 166 89

20136,986IMS201320 25.1%9.2% 75%2015 GMP 2011 201512 5001002015 50% 2011 201512 30 200 MENET201374.3% 90

2013 % 2008 2013... 18.8% 18.0%... 15.3% 6.2%.... 14.4% 18.1%.... 14.1% 19.2%... 11.8% 17.7%... 10.9% 22.3%... 3.4% 20.6%.... 3.1% 21.4%.... 1.9% 17.0%... 1.4% 17.1%... 4.9% 17.4% MENET 19932008 201225% HPV 1998 2003 2008.... 0.1% 0.1% 0.2%.... 0.1% 0.1% 0.1% 91

1993352008108 201240% 80% 92 1998 2003 2008.... 1.4% 1.4% 1.8%.... 0.6% 0.7% 1.0%... 1.6% 2.6% 5.5% III 1. II 2. IIII 3.

(International Diabetes Federation)2013 38298.42013II 80% 1993200814 20122% 1998 2003 2008... 0.5% 0.8% 1.3%... 0.3% 0.6% 1.1% 19932008 2012 1% 201326 93 1998 2003 2008.... 0.2% 0.2% 0.2%... 0.5% 0.4% 0.4% EIUMENET IMSBusiness Monitor InternationalEspicomBCC Research

2011 2011122420121302007121 2007 20131228 94

GMP 200112120131228 2002915 5 6 95

GMP GMP GMP 201182 6GMP 2007101 I IIIII IV 96

5 I (1) (2)(3) (4) (5)(6) 200917 (1) (2)(3) (4) I 97

3 5 6 GSP 5 6 98

GSP GSP20034 242000712013 61GSP5 3 201431 2000412014212201461 200489 56 99

199311 20 10 19822013830 2002822014429 19921014199311 100

19981214 2007710 2010 201120121231 5.3644.734 1999512 101

15% 2009818 2009818 2013313 102

2006519 115%125% 20121231 201321 2000221 103

200077 200188 2002313 200111 2009117 2010715 104

2007313200751 1 198891 1994751995112009 8272007629 20081120121228201371 2008918 2002111 201131 105

20101028 2011711995122 2003427 20041120101220 5003,000 0.05% 1996129200885 1996620 199671 142 2008829142 106

2012111920121217 59 59 200510212005111 75 59(1) (2) (3) 30 75 59 (1) (2)(3) 75 107

200688 2009622 2003920052 95.93%4.07% 198912262014424 20021028200391 2000429200091 108

19841112008228 19961029199731 198711 19932000 1993103120131025 20131025 20091226201071 109

2007126 25%15% (1) (2) (3) (4)(5) 25% 200811 10% 10% 110

1993121320081110 20081218 2011102820091 15% 1993121320081110 20111028 200911 17% 2006821 25%10% 25% 5% 1993 1999200420052013 19862000 19902001 10% 50% 111

2008414 (1) 5 (2) (3) (4) (5) 60%(6) 200878 (1)(2) (3)(4) (5) (6) 112

(4) 113

199468Yantai Bio-technology Co. Ltd. Yantai Bio-tech Yantai Bio-tech62.5% 37.5% 2004 20037 22012 20121129 1994 1995 19955 1998 19981 1999 2001 2003 20032 2004 2006 2007 43.0% 114

2009 綠葉製藥集團有限公司 26.6% 69.6% 2011 1998 1998 1999 2000 2001 2003 2007 2008 115

2009 Certificate of Manufacturing Facility 2010 2011 SGS United Kingdom Ltd.ISO9001:2008 2011 2012 2013 20 199468 8.0Yantai Bio-tech62.5%37.5%Yantai Bio-tech 116

1999 51Yantai Bio-tech91.5% 200362,264,400 4.4%2003995.9% 20053 201466Yantai Luye Pharma Holdings Co. Ltd.Yantai Luye Pharma Holdings Co. Ltd. 43,590,000 Yantai Luye Pharma Holdings Co. Ltd. 271.8 1997327 1.0 80%14%3%3%200262006 5 20.0 2002222 1.01Solid Success 2007100%20071 Hui Tin Cho345.0Solid Success 117

280.015.0 50.0 Solid Success 2008111Solid SuccessSolid SuccessApex Group HoldingsKang Hai Pharmaceutical Apex Group HoldingsKang Hai Pharmaceutical 200712Apex Group HoldingsKang Hai Pharmaceutical75% 75%20108 70.0 Kang Hai PharmaceuticalApex Group Holdings75%21.4%3.6%. 199491Peking University Technology Development Department 80.0 2007 Peking University Weiming Biotechnology Group 30.4% 43%26.6%200710 43%19,871,88020071023 200911Beijing Enterprises Biotech Limited Luye Hong KongPacific Target Holdings Limited26.6% 102,040,00069.6% Beijing Enterprises Biotech Limited 5,260,5002009 11 20113Luye Hong Kong69.6% 80.0 118

20001221 36.0 2011100% 99.7%0.3%201171 288 2012521 200455AsiaPharm Group Ltd.20093 2012828 1.30 20127 271.12 551.9 92.64% 6.61% 99.56% 103 20121129 119

248,711,018.31 80 2.8%4.75% 20141 20142 15% 70% 15% (1) 0.01 (2) CDH FlowerCPE GreeneryBeyond Border0.01 201277.41% Hygeia Holdings Limited 2012228Hygeia Holdings Limited 120

12 105,480 92.63% 7.37% 12 20.4%39.8%41.3% CDH FlowerCPE GreeneryBeyond Border 2012128 248,711,018.31 0.01 121

: 248,711,018.31 : 2012228 212,183,974.70 2012725 36,527,043.61 : 0.221.745.65 69.3% : : 10% : LPH Group 304 0.01 122

: LPH Group 0.22 : (i) Hygeia Holdings Limited (ii) (iii) : LPH Group CompanyLPH Group : : LPH Group CompanyLPH GroupLPH Group 123

: 60% 40% 10% : 75% 60% 40% 124

1,110,503,913CPE Greenery 267,902,223CPE Palm Beach L.P.CPE Coinvest Management Limited CPE Palm Beach L.P.CPE GreeneryCPE Coinvest Management LimitedCPE Greenery 267,902,223Tropical ExcellenceCPE Palm Beach L.P. CPE Coinvest Management LimitedTropical Excellence 267,902,223CPE GreeneryCPE Palm Beach L.P.CPE GreeneryCPEChina Fund, L.P. CPE Greenery 306,797,245 Tropical ExcellenceGIC Special Investments Pte. Ltd.GIC Special Investments Pte. Ltd. GIC Private LimitedGIC Private Limited CDH Flower CPE GreeneryBeyond BorderTropical Excellence 6.4%6.8%5.4%5.9%Tropical Excellence 10% 8.08 HKEx-GL29-12HKEx-GL43-12HKEx-GL44-12 125

CDH Flower CDH FlowerCDH Pharmaceutical Investments Limited CDH PIL CDH PILCDH Fund IV, L.P. CDH Fund IV CDH IV Holdings Company Limited CDH Fund IVCDH China Management Company Limited CDHCDH Fund IVCDH CPE Greenery CPE GreeneryCPEChina Fund, L.P. CPEChina CPE Palm Beach L.P. CPE Palm Beach CPEChinaCITIC PE Associates, L.P.CITIC PE Funds LimitedCPE Palm Beach CPE Coinvest Management LimitedCPEChina CPE Palm BeachCPEChina CPE Greenery 267,902,223CPE Palm Beach CPE Coinvest Management Limited CPE Palm BeachCPE GreeneryCPE GreeneryCPEChina Beyond Border Beyond BorderHarvest Hill Investment Ltd. HHI AXA Direct Asia II,L. P. AXA FundHHINew Horizon Capital III, L.P. NHCNHC New Horizon Capital Partners III Ltd. New Horizon New Horizon AXA Fund AXA FundAXA PE Asia Manager Limited AXA Fund 126

2014519Nelumbo Investments Limited 70% Nelumbo Investments LimitedGinkgo Trust LimitedGinkgo Trust LimitedShorea LBG 2014620136,852 0.01 12.0% 2 127

Ginkgo Trust Limited (1) Nelumbo Investments Limited * 15% 70% 15% * * (2)(3) * * * Luye Hong Kong * * Yantai Luye Pharma Holdings Co. Ltd. * Luye Pharma Investments Pte. Ltd. * AsiaPharm Biotech Sdn. Bhd. ^ AsiaPharm Biotech Pte. Ltd. ^ 36.0% Steward Cross ^ (4) Solid Success * # SmartMedicine Sdn. Bhd. (5) Kang Hai Apex Group Holdings Pharmaceutical * * 3.6% 21.4% Shandong Luye Natural Drugs R&D Co. Ltd. # (6) (8) # 75.0% 69.6% Shandong Langhe Biotech Co. Ltd. Luye Biotech (Singapore) Pte. Ltd. A-Bio Pharma Pte. Ltd. (7) Nanjing Kanghai Phospholipid Biotech Technology Co. Ltd. # Shanghai Ge Lin Li Fu Business Consulting Co. Ltd. (9) ^ 0.3% 99.7% # Chengdu Bomai Technology Co. Ltd. 128

* # ^ (1) Ginkgo Trust LimitedShorea LBG Nelumbo Investments Limited (2) 0.0112.0% (3) CDH FlowerCPE GreeneryBeyond Border0.01 (4) Steward CrossSiow Kwong ThyeMichael Tay Poh ChoonGrace Yip Yin May Ng Swee Pheng20%7%27%10% (5) SmartMedicine Sdn. Bhd (6) (7) A-Bio Pharma Pte. Ltd. (8) Beijing Beida Asset Management Co. Ltd.Beijing Beida Asset Management Co. Ltd. (9) Shanghai Ge Lin Li Fu Business Consulting Co. Ltd. 129

Ginkgo Trust Limited (1) Nelumbo Investments Limited * 15% 70% 15% * * * * CDH Flower CPE Greenery Beyond Border Tropical Excellence 30.1% 45.4% 6.4% 6.8% 5.4% 5.9% * Luye Hong Kong Luye Pharma Investments Pte. Ltd. * * * Yantai Luye Pharma Holdings Co. Ltd. * Asia Pharm Biotech Sdn. Bhd. ^ AsiaPharm Biotech Pte. Ltd. ^ 36.0% Steward Cross ^ Solid Success * # SmartMedicine Sdn. Bhd. Apex Group Holdings Kang Hai Pharmaceutical * * 3.6% 21.4% # # 75.0% 69.6% Shandong Luye Natural Drugs R&D Co. Ltd. Shandong Langhe Biotech Co. Ltd. Luye Biotech (Singapore) Pte. Ltd. A-Bio Pharma Pte. Ltd. Nanjing Kanghai Phospholipid Biotech Technology Co. Ltd. # Shanghai Ge Lin Li Fu Business Consulting Co. Ltd. ^ 0.3% 99.7% # Chengdu Bomai Technology Co. Ltd. 130

29 201120122013 92.2%85.9%83.6% MENET2013 2013 2013IMS MENET 2013 20132013 IMS MENET 2013IMS2013 2011201220131,577.6 1,864.62,215.188.9% 87.3%88.1%18.5% 201350 1,30050080030 8,000 132

2013123122 2020172018 MENET20082013201312 3126630124 2013123123084 7577 2011 2012 153.72013238.955.4% 20131231 20131231 30 133

2011201220131,774.4 2,135.92,515.119.1%2011 20122013166.2175.6 327.940.5%201120122013 83.0%83.5%83.6% 2012 MENET2013 18.8%IMS2013 201120122013799.9 940.81,102.245.1%44.1%43.8% 2012 MENET2013 14.4% IMS 20132013 201120122013 613.9630.7723.1 34.6%29.5%28.7% 134

MENET2013 14.1%IMS2013 201120122013 280.0451.1575.2 15.8%21.1%22.9% MENET20082013 22.3%20131231 2011201220131,577.6 1,864.62,215.188.9%87.3% 88.1% IMS2013 302IMS2013 38.9%2013 1231 IMS2013946IMS 2013 20131231 2009 135

20131231IMS2013 65IMS2013 1.9%IMS2013 99.1% IMS2013 18IMS2013 201318.7% II 20131231IMS 201324IMS2013 3.0% IMS201322 IMS2013 13.5% 136

2013123122 2020 201817 2014 137

IMS2013 222011201316.4% 2015 IMS2013 342011201317.5% 2016 IMS2013 30220112013 18.3%201362016 IMS2013 1420112013 24.6%2016 IMS 2013172011 201329.0% 2017 138

IMS 2013516.820112013 24.3% 2017 II IMS2013 772011201323.4% 2017 SNDRI IMS2013 292011201321.2% 2018 II II IMS2013 782011201323.4% 20146 2019 139

505(b)(2) 2013 3050 1,300500800 8,0002013 1,12365.0% 2,487 37.3% 4,43727.9% 140

(i) (ii) (iii) (iv) 20062007 2008 194.22013 847.234.3%2009 201313.5%2010 268.62013 338.52011 2012 153.7 2013238.955.4% 141

22 24 20 14 25 20 23 15 12 20042012 142

2015 143

144

20131231 2013123130 145

201120122013166.2 175.6327.99.4%13.0% 146

29 24 1231 2011 2012 2013 % % %... 799,921 45.1 940,830 44.1 1,102,165 43.8.... 613,926 34.6 630,654 29.5 723,079 28.7.... 280,038 15.8 451,086 21.1 575,237 22.9... 80,505 4.5 113,373 5.3 114,630 4.6... 1,774,390 100.0 2,135,943 100.0 2,515,111 100.0 1231 2011 2012 2013 % % %.... 584,160 32.9 699,912 32.8 847,155 33.7.... 162,630 9.2 181,673 8.5 185,757 7.4.... 34,072 1.9 36,891 1.7 43,330 1.7.... 326,228 18.4 295,887 13.9 338,453 13.5.... 244,131 13.8 285,859 13.4 333,532 13.3... 34,621 1.9 153,653 7.1 238,919 9.4.... 191,775 10.8 210,711 9.9 227,910 9.1 1,577,617 88.9 1,864,586 87.3 2,215,056 88.1.... 196,773 11.1 271,357 12.7 300,055 11.9... 1,774,390 100.0 2,135,943 100.0 2,515,111 100.0 (1) 19952001 2003 147

H20030357 2015929 ZL00119039.3 RU2264807 IDP0025604 IN205351 IN208865 EP1332755 H10950078 2015929 ZL03112908.0 US7091336 RU2303978 ID0017474 IN193666 IN206223 H20070031 2017311 EP1043316 H20070022 2017311 US6271250 JP4598227 ZL03151291.7 ZL201310081158.1 20201018 2021228 2021227 2021227 2021227 2021227 202333 2021414 2021228 2021227 2021227 2021227 202044 202045 202046 2023928 2033313 Z10950029 2017123 70 2017 2028 H20003240 H20023113 H20003239 2015929 2015929 2015929 CN99103226.8 CN99815996.4 US6475520 CN03136127.7 2019328 20191229 20191229 2023514 H20020391 2015829 ) H20041619 H20041620 H20030002 H20030001 2015929 2015929 2015929 2015929 ZL201110004370.9 2031110 148

20112012 2013799.9940.8 1,102.217.4%MENET 201318.8%IMS 2013 2012 201330220112013 18.3%IMS2013 17.8%IMS2013 2013 38.9%.201127.4%2013 38.9% 20131231 2012 2013 2003 20201018 2015929 149

2013123126 201319775 201333.7%20112013 20.4%20.1% 1999 IMS2013946.0 2011201314.8%IMS2013 201327.6% 1995 202333 2015929 2013123118 2013175102013 7.4%201120136.9% 5.2% 150

20131231 200960 2105,676 20022003 2006 20239282033313 2017311 20131231 2013141432013 1.7%2011201312.8% 16.0% 201120122013613.9 630.7723.18.5% Lipascor 20131231 151

20075 19965200312 654,700 30%-33% LDL-C HDC C2008 IMS2013 652011 201334.7%IMS 20131.9%IMS 2013 99.1% 1995 20172028 2017123 2013123120092012 2013256,7952013 13.5%201120131.9% 2.6% 201310 152

IMS2013182011 201312.9%2013 IMS20132013 18.7% 1995 20193282019 12292022 49 2023514 2015929 20131231 2013191,6232013 13.3%20112013 16.9%18.9% 201120122013 280.0451.1 575.243.3%IMS2013 153

II 20131231 2007 II 2013II IMS201324 2011201312.6%IMS 20133.0% 20022003 2015829 GMP 201312312012 2013151,6862013 9.4%20122013 55.4%53.5% ) 154

IMS201322 2011201316.4%IMS2013 13.5% 20012003 2031110 2015929 20131231 2013171,2672013 9.1%201120139.0% 13.4% 155

501,300 5008002013 308,0002013 1,12365.0%2,48737.3% 4,43727.9% 156

20062007 2011 20%30% 157

158

700 201120122013 1% 159

160

30800 201312311,123 65.0%2,48737.3% 4,43727.9% 201120122013 1231776931842 20131231 96 112 102 98 81 220 133 161

2011201220131231 2011 2012 2013... 534 776 931... 341 335 176... 99 180 265... 242 155 (89)... 776 931 842 (1) (2) (3) (4) (5)GSP 5% 201120122013 276.8343.6399.1 15.6%16.1%15.9% 63.9104.9123.7 3.6%4.9%4.9% 2013 201120122013 162

9.6%11.0%10.8% GSP 3090 163

0.8 1 GSPGSP GSP GSP 164

80%97% 19 19 165

20112012201319 54.2%55.4%56.0% 2011 2012201344.3%43.4% 43.0% 201189 201120122013 15.7%20.6%22.8% 15%201220113% 20112012 20125 201120122013 10.8%9.9%9.1%19% 201220115% 201210 20132012 3% 20118920125201210 201111 201120122013 1,774.42,135.92,515.1 19.1%201120122013 1,473.31,784.12,101.6 19.4%20112012201383.0%83.5% 166

83.6% 1613 2020 167

20131231266 301249 168

2013123111 20131231 2012 169

25 1996 20131231 BCC 201215201733.7%66 2013123120 2010 20131231 20131231 FDA 170

6.5%201120122013 134.9134.4194.1 7.6%6.3%7.7% 171

172 20131231200883 2018 17

20131231222020 172018 (1) (1) 2015 2016 2017 2017 2014 2019 2020 2020 173

(1) (1) 2015 2016 2020 2017 2016 2018 2016 2017 2016 174

(1) (1) 2018 2019 2017 2017 2015 (1) 20131231 90%40% NGT 2014 175

IMS201322 2011201316.4% 2015 19932001 IMS201334 2011201317.5% 2016 Midas Pharma GmbHMidas Pharma GmbH 176

IMS20133022011 201318.3% 2024 20136 2016 2010 20002007 IMS2013142011 201324.6% 2016 177

2012PCT 2014PCT IMS2013 172011201329.0% 2017 20052025 IMS2013516.8 2011201324.3% 2017 178

1II IMS201378 2011201323.4% 2017 (SNDRI) SNDRI 20062026 IMS2013292011 201321.2% 2018 179

IV (DPP IV) II II 2029 IMS201378 2011201323.4% 2014 2019 20131231 180

505(b)(2) 505(b)(2) GMP 181

22 85 182

656 183

20131231326,351 155,4782013123130 12 2015 GMPGMP 1231 2011 2012 2013 (1) (%) (1) (%) (1) (%) (2)... 10,000 3,744 4,188 111.9 (3) 4,265 397 93.1 5,765 5,207 90.3 (4)... 10,000 44,000 5,458 12.4 44,000 5,682 12.9 44,000 5,792 13.2 (5)... 10,000 5,000 780 15.6 5,000 962 19.2 5,000 1,038 20.8 (6)... 10,000 13,000 6,483 49.9 13,000 2,720 20.9 13,000 1,576 12.1 (7)... 10,000 80,000 52,513 65.6 80,000 56,862 71.1 80,000 77,392 96.7 (8)... 10,000 400 57 14.3 400 62 15.5 400 35 8.8 (9)... 10,000 4000 363 9.1 4,000 367 9.2 4,000 537 13.4 (10)... 203,874 42,969 21.1 203,874 45,212 22.2 204,174 76,021 37.2 (1) 2608 (2) (3) 20118 2011100% 184

(4) (5) (6) (7) (8) (9) (10) 58,43326,352 2013 123112 2015 2012 132,85043,242 20131231 185

37,34830,552 20131231 48,15432,961 20131231 49,56622,371 20131231 186

2016... 2016 583.... 325.... 151.... 51... 1,110 1282,200 20131231 90.3%96.7% 187

; 2213 20151231 201420152016 1,110 1993GMP 3 GMP GMP 188

GMP 7 20112012201363.2 94.6137.039.5%45.3% 48.9%, 31.542.757.3 19.6%20.5%20.5% 5% 189

201446201310 GMP GMPISO9001:2008 ISO14001:2004CNAS 2013123197 GMP 190

201312 3188 GMP GMP GMP GMP 191

2012 201120122013 1.20.61.8 192

2013123123084 75773129 78 201120122013 193

2013123126210 35,801155,478 16 2,014132,850326,263201312 31 262 194

21,4404% 2,779 2007 2013123130 20143 100,000 20131231 5,923 5.0120131231 13.9% 15%5 32L 6(2) 342(1)(b)34(2) 195

20042012 2006 (i)(ii) (iii) (iv) 2013128 (i) (ii) (iii) 196

30 197

20151231 20151223 20151231 20151231 20141027 GSP 2019523 20161219 GMP (CN20120133) 20171122 (1) GMP (SD20110009) 20161129 198

GMP (Lu L0736) 201589 GMP (Lu I0422) 20151231 GMP (Lu J0484) 20151231 (2) GMP (Lu M0798) 2016215 GMP (BJ20120024) GMP (CN20130523) GMP (CN20130535) 2017123 (3) 20181222 (4) 20181222 (5) 199

GMP (JS20120097) 2018110 GMP (SC20130002) 201842 (6) GMP (CN20140076) 2019217 (7) (1) (2) (3) (4) (5) (6) (7) GSP 20141027 20145 200

201312313,2893,27019 2011201220131231 1231 2011 2012 2013 % % %... 632 22.8 717 23.9 868 26.4... 231 8.4 249 8.3 266 8.1.... 139 5.0 167 5.6 190 5.8... 1,200 43.3 1,323 44.0 1,372 41.7... 569 20.5 548 18.2 593 18.0... 2,771 100.0 3,004 100.0 3,289 100.0 201

GMP GMPGMP 202

GMPGSPISO9001:2008ISO14001:2004 201120122013 1,400,0004,600,000 2,000,000 2013 2011Beijing Haidian Environmental Protection Bureau 42,462.9620117 203

2011201220131231 20131231 29 20112012201392.2%85.9%83.6% 201120122013 1,577.61,864.62,215.1 88.9%87.3%88.1%18.5% 201120122013 799.9940.81,102.2 45.1%44.1%43.8% 17.4% 201120122013613.9 630.7723.134.6% 29.5%28.7%8.5% 201120122013 280.0451.1575.2 15.8%21.1%22.9%43.3% 204

201120122013 1,754.22,116.5 2,495.198.9%99.1%99.2% 2013 501,300500800 308,000 20131231 222020 10 2013123123084 7577 20131231 20131231 30 2011201220131,774.4 2,135.92,515.119.1% 201120122013166.2175.6 327.940.5%20112012 201383.0%83.5%83.6% 205

Espicom20083452012697 19.3%20111,774.4 41.7%20132,515.1 2011201317.4%8.5%43.3% Espicom2013201718.8% 2011 20122013134.9134.4 194.17.6%6.3%7.7% 20131231222020 22 2016 206

2015 20131231 20112012 12315.3644.734 19 192011 2012201319 54.2%55.4%56.0% 2011 20122013 207

44.3%43.4%43.0% 201189 201120122013 15.7%20.6%22.8% 15%201220113% 20125 201120122013 10.8%9.9%9.1%19% 201220115% 201210 20132012 3% 201120122013 1,774.42,135.92,515.1 19.1%2011201220131,473.3 1,784.12,101.6 19.4%20112012201383.0%83.5%83.6% 208

(i) (ii) (iii) (iv) 20117 1 209

2012 153.72013 238.955.4% 15% 25% 201120122013 25.029.537.7201120122013 30.438.449.5 2014 201313.0%201220118.2%9.4% 210

2012 201354.8%2012201156.6% 55.2% 2.3 211

1231 3% 2011 20122013123114%14%15% 20131231347.4 2011159.1 2.3 3 16 212

3 22 23.... 1040...................... 510.... 510... 310 213

2.3 3 1417 214

2011 2011 2013123122 202022 2.3 215

1231 2011 2012 2013 % % %... 1,774,390 100.0 2,135,943 100.0 2,515,111 100.0.... (301,121) (17.0) (351,813) (16.5) (413,506) (16.4)... 1,473,269 83.0 1,784,130 83.5 2,101,605 83.6... 25,934 1.5 12,717 0.6 35,902 1.4... (980,111) (55.2) (1,209,717) (56.6) (1,378,061) (54.8).... (151,566) (8.5) (157,906) (7.4) (146,508) (5.8).... (147,307) (8.3) (145,522) (6.8) (206,669) (8.2).... (19,636) (1.1) (29,145) (1.4) (24,091) (1.0)... 545 0.0 894 0.0 990 0.0.... 201,128 11.4 255,451 11.9 383,168 15.2.... (34,902) (2.0) (79,862) (3.7) (55,224) (2.2).... 166,226 9.4 175,589 8.2 327,944 13.0... 155,752 8.8 169,032 7.9 310,498 12.3... 10,474 0.6 6,557 0.3 17,446 0.7 216

1231 2011 2012 2013 % % %... 799,921 45.1 940,830 44.1 1,102,165 43.8.... 613,926 34.6 630,654 29.5 723,079 28.7.... 280,038 15.8 451,086 21.1 575,237 22.9... 80,505 4.5 113,373 5.3 114,630 4.6... 1,774,390 100 2,135,943 100 2,515,111 100 20112013 1231 2011 2012 2013 % % % (%) (%).... 584,160 32.9 699,912 32.8 847,155 33.7 20.4 20.1.... 162,630 9.2 181,673 8.5 185,757 7.4 6.9 5.2.... 34,072 1.9 36,891 1.7 43,330 1.7 12.8 16.0.... 326,228 18.4 295,887 13.9 338,453 13.5 1.9 2.6.... 244,131 13.8 285,859 13.4 333,532 13.3 16.9 18.9... 34,621 1.9 153,653 7.1 238,919 9.4 55.4 (1) 53.5 (1).... 191,775 10.8 210,711 9.9 227,910 9.1 9.0 13.4... 1,577,617 88.9 1,864,586 87.3 2,215,056 88.1.... 196,773 11.1 271,357 12.7 300,055 11.9... 1,774,390 100 2,135,943 100 2,515,111 100 (1) 20122013 217

(2) 19952001 2003 201120122013 92.2%85.9%83.6%201120122013 0.5%0.8%1.0% 1231 2011 2012 2013 % % %.... 152,516 50.6 176,537 50.2 199,711 48.3.... 51,542 17.1 68,967 19.6 80,784 19.5... 42,432 14.1 38,608 11.0 37,299 9.0... 17,453 5.8 19,739 5.6 39,807 9.6... 36,528 12.2 47,676 13.5 55,663 13.5 (1)... 300,471 99.8 351,527 99.9 413,264 99.9... 650 0.2 286 0.1 242 0.1... 301,121 100 351,813 100 413,506 100 218

(1) 2011201220131,195,000 584,0001,757,000 23%26% 2011201220122013 2011201220122013 20112013 201150.6%2013 48.3%201183.0%201383.6% 2011201220131,473.3 1,784.12,101.6 83.0%83.5%83.6% 219

1231 2011 2012 2013.... 17,519 5,469 30,839... 4,823 3,858 3,030.... 1,499 763 1,008... 2,093 2,627 1,025... 25,934 12,717 35,902 220

1231 2011 2012 2013 % % %.... 346,558 35.4 502,146 41.5 688,124 49.9.... 213,489 21.8 232,397 19.2 209,443 15.2.... 112,745 11.5 141,743 11.7 167,682 12.2.... 123,241 12.6 123,526 10.2 121,007 8.8.... 106,341 10.8 136,150 11.3 117,329 8.5... 77,737 7.9 73,755 6.1 74,476 5.4... 980,111 100 1,209,717 100 1,378,061 100 1231 2011 2012 2013 % % %.... 60,492 39.9 72,025 45.6 72,932 49.8... 18,962 12.5 20,793 13.2 13,955 9.5... 24,718 16.3 12,559 8.0 10,557 7.2... 18,115 12.0 11,296 7.2 10,551 7.2.... 5,804 3.8 17,270 10.9 10,001 6.8... 23,475 15.5 23,963 15.2 28,512 19.5... 151,566 100 157,906 100 146,508 100 221

201120122013 134.9134.4194.1 91.6%92.3%93.9%201120122013 7.6%6.3%7.7% 28 1231 2011 2012 2013... 22,789 34,425 26,519... (3,536) (5,796) (2,596) 19,253 28,629 23,923... 32 33 32... 19,285 28,662 23,955... 139... 212 483 136 19,636 29,145 24,091 36%Steward Cross2007AsiaPharm Biotech Pte. Ltd.Steward Cross Steward Cross 20131231Steward Cross Steward Cross20110.5349,000 64.0%20120.996,00010.7%2013 1.0 222

1231 2011 2012 2013... 73,313 57,599 87,053... 25 5,058 1,612.... (38,436) 17,205 (33,441)... 34,902 79,862 55,224 10 223

2013123120121231 20122,135.9379.217.8% 20132,515.1 20121020125 2012940.8161.3 17.1%20131,102.2 2012699.9147.3 21.0%2013847.2 20122013 2012181.74.1 2.3%2013185.8 201236.96.4 17.3%201343.3 201210 2012630.7 92.414.7%2013723.1 2012285.9 47.616.6%2013333.52012 224

295.942.614.4%2013338.5 20122013 201310 2011 2012451.1 124.227.5%2013575.2 2012153.785.2 55.4%2013238.92011 2012 2013 2012210.717.2 8.2%2013227.9 20125 2012113.4 1.31.1%2013114.6 2012351.861.7 17.5%2013413.52013 201220132012 20121,784.1317.517.8%2013 2,101.6 2012201383.5%83.6% 225

20121,209.7168.3 13.9%20131,378.1 201256.6%2013 54.8% 2012 20132012 2011 2012 2012 574.4149.126.0%2013723.5 2012305.381.126.6% 2013386.52012 177.646.426.1%2013224.0 201285.48.49.8% 201393.720126.1 13.2218.3%201319.3 201212.723.2 182.3%201335.92013 201330.8 20125.5 20121231111.82013 1231153.1 2012157.911.47.2% 2013146.5 2012 20127.4% 20135.8% 226

2012145.561.242.1% 2013206.7 2012134.444.4%2013 194.120126.3%20137.7% 6.5%2013 201229.15.017.2% 201324.12013 2012 2012 20121231444.920131231 735.9201312 304.8 201280 201279.924.730.9%2013 55.220132012 30.9 10% 2012 201249.06.212.7% 201355.22012 2012201219.2% 201314.4%20132013 2012 2012175.6152.386.7%2013 327.9 227

2012123120111231 20111,774.4361.520.4% 20122,135.9 20112012 20112012 2012201171 201134.6 2012153.7 20111,739.8242.513.9% 20121,982.3 2011799.9140.9 17.6%2012940.8 2011584.2115.7 19.8%2012699.9 2011162.619.0 11.7%2012181.7 2013 2012 201134.12.8 8.2%201236.9 201210 2011613.9 16.72.7%2012630.7 2011244.141.8 17.1%2012285.9 228

20128 20122011 3% 2011326.230.3 9.3%2012295.92012 2012 2011 2011280.0 171.061.1%2012451.12011 71 2011245.452.0 21.2%2012297.4 20117120111231 34.62012153.7 20122011 2011191.818.9 9.9%2012210.7 20125 20122011 5% 201180.5 32.940.8%2012113.4 229

2011301.150.7 16.8%2012351.82012 2011 2012 20111,473.3310.9 21.1%20121,784.120112012 83.0%83.5% 2011980.1229.6 23.4%20121,209.7 2012 201155.2%201256.6% 2011493.281.216.5% 2012574.42011243.4 61.925.4%2012305.3 2011172.25.43.1%2012 177.6201166.1 19.329.2%201285.4 201111.55.447.0%2012 6.1201171 201125.913.2 51.0%201212.72012 2011123188.820121231 111.8 2011151.66.34.2% 2012157.9 20118.5%20127.4% 230

20112012147.3 145.52011 2012134.9134.4 20117.6%20126.3%6.5% 2012 201119.69.548.5% 201229.12012 20124 40.220117 20111231455.8 20121231470.8 201134.945.0128.9%2012 79.92012 10% 30.92012 201134.914.140.4%2012 49.02012 2012201117.4% 201219.2% 2011166.29.45.7%2012 175.6 231

1231 2011 2012 2013.... 313,420 152,902 439,626.... (608,112) (135,130) (554,376).... 144,963 91,517 87,320.... (149,729) 109,289 (27,430).... 400,135 251,501 364,031.... 251,501 364,031 333,150 2013439.6 38.1505.9 26.478.0 (i)77.3 (ii) 36.9Shandong Biological Technology Group (iii)15.9(iv) 15.0 20141 (i)92.0 (ii)21.3 232

2012152.9 106.0 363.934.270.8 (i)58.9 (ii)36.4 (iii)35.9 (i)20.1 (ii) 13.6 2011313.4 101.422.8 294.359.5 (i)163.8 (ii)29.8 (iii)23.4 99.0 20112013 2013554.4 2013302.6 265.0 2012 80 233

2012135.1 2012146.2 2011608.1 2011297.3 271.9 201387.3 201291.5 2011145.0 234

1231 430 2011 2012 2013 2014... 106,272 142,686 234,733 239,583.... 455,326 514,258 535,562 602,345... 36,178 35,092 46,413 91,523... 3,755 12,212 314,209 532,451... 79,009 2,464 177,485 230,394... 10,000... 251,501 364,031 333,150 319,197 932,041 1,070,743 1,651,552 2,015,493.... 17,825 818 932,041 1,088,568 1,652,370 2,015,493.... 34,331 54,403 69,369 52,176.... 325,619 313,127 351,913 271,129... 453,815 444,863 735,921 1,081,157... 28,310 45,218 74,436 74,056.... 32,010 26,589 34,488 57,890... 4,902 36,856 755 878,987 884,200 1,302,983 1,537,163... 53,054 204,368 349,387 478,330 20131231349.42012 1231204.4 20141 235

20121231204.42011 123153.1 2014430 20131231349.42014430 478.3 201443020131231 535.6602.32014430 20144301,081.9 319.2 802012 2014430532.5 2.3 236

1231 2011 2012 2013... 34,039 50,901 95,854... 40,503 53,883 81,523... 31,730 37,902 57,356 106,272 142,686 234,733 1231 2011 2012 2013 (1)... 109.4 129.1 166.6 (1) 365 2012142.72013234.7 20141 2015 2011106.32012142.7 201120122013109.4129.1 166.6 3090 237

1231 2011 2012 2013... 313,792 339,525 393,459.... 144,880 176,806 144,295 458,672 516,331 537,754... (3,346) (2,073) (2,192) 455,326 514,258 535,562 1231 2011 2012 2013 (1)... 57.9 55.8 53.2 (1) 365 2011201220131231 313.8339.5393.5 20112012201357.955.8 53.2 1231 2011 2012 2013 3.... 268,824 311,934 370,021 36... 36,622 12,316 18,139 612... 4,009 9,956 2,346 12.... 2,570 3,743 813 2... 1,767 1,576 2,140 313,792 339,525 393,459 238

1231 2011 2012 2013... 246,049 315,009 386,232 3... 52,710 10,401 2,817 3... 11,687 12,042 2,218 310,446 337,452 391,267 201120121231 4.97.7 20131231 1231 2011 2012 2013... 34,331 50,049 56,266.... 4,354 13,103 34,331 54,403 69,369 239

1231 2011 2012 2013 (1)... 33.1 43.8 46.9 (1) 365 201120122013123134.3 50.056.3 2013 20112012201333.143.8 46.9 1231 2011 2012 2013 3.... 25,007 44,436 66,073 36.... 8,076 7,507 2,023 612.... 996 2,021 765 12... 156 310 142 2... 96 129 366 34,331 54,403 69,369 90 2012201312314.24.6 4.24.6 12 240

20131231745.3 724.420.0 0.9 2014430 1,081.91,044.2 36.90.82014430 2014430 5.04%6.77% 2014430 20131231724.42013 1231163.6 73.2 20131231410.9 20135.7% 201312318.6 2012323 20112013 6.8%2015428 20131231 304.820132.5% 241

802012 20141215231 201412 19 2013123120.0 20135.6% 2014430 201120122013376.2 171.1215.7 20142015881 28 293839 242

12311231 2011 2012 2013 % % % (1)... 11.8 11.1 17.3 (2)... 6.8 6.6 9.7 (3)... 106.0 123.1 126.8 (4)... 14.5 6.7 21.7 (5)... 18.7 17.6 22.0 (1) (2) (3) (4) (5) 201120122013123111.8%11.1% 17.3% 2011 2013 20112012201312316.8% 6.6%9.7% 2013 2011201220131231106.0%123.1% 126.8% 201120122013123114.5% 6.7%21.7%2011 2013 243

20132013 2011 201120122013123118.7% 17.6%22.0% 2011 2013 30%80% 43 244

43 4322 23 43 245

4.29 20131231 20131231 20131231 2013 1231 (1) (2) 2013 1231 (3)(4) 20131231 (3)(4)(5)(6) 5.38... 1,285,385 2,737,347 4,022,732 1.21 1.51 5.92... 1,285,385 3,016,824 4,302,209 1.30 1.62 (1) 20131231.... 1,897,695.... (128,653).... (347,356).... (136,301)... 1,285,385 (2) 5.384.31 5.92 4.74667,540,000 0.80101 (3) 20145 52,865,878324,339,0001.006.1351 51,932,992200,000,000 1.325.38 1.42 5.92 246

(4) 20131231 20131231 (5) 201312312 201312313,321,073,843 (6) 0.80101 40 20131231 308.7 802012 2014331524.3 20145 52,865,878 1.006.1351324.3 247

20051,932,992 20131231 70%15%15% 12.9 12.0 953,000 2014 2014 20131231Steward Cross36% 2.3 2014331Steward Cross1.87 0.432014 20131231AsiaPharm (Singapore) Pte. Ltd.2.00.9 2014 20131231 0.232,000 2014 2013123136.0 Shandong Biological Technology group 2014 2013123197.5 13.1313.19 13.13 13.19 248

5.65 144.0 37.62014 106.4 20131231 249

45.4% Ginkgo Trust Limited 70% 15% 2001416 90%10% 70%15% 2011201220131231121.6 114.9123.86.7 9.33.1 2001 19942001 250

2004 201353%17%8% 2090 2014620 12248118 201120122013 92.2%85.9%83.6% 251

2014 620...... 122 252

GSPGMP 2014620 30 3012 2014324 50,000 253

254

2014619 10% (i) 30%(ii) 255

256

201471 14A14A 20131220 117,863,262 39 39 24,251.70 2014 117,863,262 15... 2014630... 2015630... 2016630... 2017630... 5 7 9 1.1 70%15%15% 257

14.07 0.1%5%14A14A.76 2014619 258

10,000,000,000 200,000,000 440,831,908 8,816,638 13.3% 2,212,701,935 44,254,039 66.6% 667,540,000 13,350,800 20.1% 3,321,073,843 66,421,477 100.0% 259

(i)(ii)(iii) (iv)(v) 2. (c) 2. (d) 20% A. 3. 260

10% A. 5. A. 3. 261

280,000,000 2,170,425,000500 5.65 384,144,00038.42% 11.56% 201478 (1) (1) (2) (2)(3) (2) Dragon Billion China Master Fund LMA SPC... 47,747,301 2,252,699 370,113,204 17,461,796 65,506,500 3,090,500 6.55% 0.31% 1.97% 0.09%.... 25,000,000 193,787,500 34,298,500 3.43% 1.03%.... 25,000,000 193,787,500 34,298,500 3.43% 1.03% OrbiMed Advisors LLC... 50,000,000 387,575,000 68,597,000 6.86% 2.07% TAL China Focus Master Fund... 30,000,000 232,500,000 41,158,500 4.12% 1.24%.... 100,000,000 775,200,000 137,194,500 13.72% 4.13%... 280,000,000 2,170,425,000 384,144,000 38.42% 11.56% 262

(1) (2) 5005.65 (3) Dragon Billion China Master FundLMA SPC Map 109 Segregated Portfolio Dragon Billion China Master Fund20087 Map 109 Segregated PortfolioLMA SPCLMA SPC200511 Dragon Billion China Master FundMap 109 Segregated Portfolio 20047 200492006320131231 23 2000721 2013 500192 OrbiMed Advisors LLC OrbiMed Advisors LLCOrbiMed OrbiMed 263

TAL China Focus Master Fund TAL China Focus Master FundTAL China Focus Master Fund Trivest Advisors LimitedTAL China Focus Master Fund 1999 806 (1) (2) (3) (4) (5) 264

265

XV 23 10%.... 1,509,819,930 45.4% (2)... 1,509,819,930 45.4% (2)... 1,509,819,930 45.4% (2)... 1,509,819,930 45.4% Nelumbo Investments Limited (3)... 1,509,819,930 45.4% Ginkgo Trust Limited (3)... 1,509,819,930 45.4% Shorea LBG (3)... 1,509,819,930 45.4% (3)... 1,509,819,930 45.4% CPE Greenery... 224,223,354 6.8% CITIC PE Funds Limited (4)... 224,223,354 6.8% CDH Flower... 212,113,258 6.4% CDH IV Holdings Company Limited (5)... 212,113,258 6.4% Beyond Border... 179,480,448 5.4% New Horizon Capital Partners III Ltd. (6)... 179,480,448 5.4% 266

Tropical Excellence.... 195,796,853 5.9% (7)... 195,796,853 5.9% (1) (2) 1,509,819,930 (3) Nelumbo Investments Limited70%Nelumbo Investments LimitedGinkgo Trust Limited Ginkgo Trust LimitedShorea LBG 201458Ginkgo Trust Limited (4) CPE Palm BeachCPE Greenery CPE GreeneryCPEChinaCPEChinaCITIC PE Associates, L.P.CITIC PE Funds Limited (5) CDH FlowerCDH PILCDH PILCDH Fund IVCDH IV Holdings Company LimitedCDH Fund IV (6) Beyond BorderHHI81.82%HHINHCNHCNew Horizon Capital Partners III Ltd. (7) Tropical ExcellenceGIC (Ventures) Pte. Ltd.GIC (Ventures) Pte. Ltd. 2(1) XV23 10% 267

11.... 48 19946 20037.... 55 19946 20037.... 49 19946 20037.... 33 20098 20143.... 38 20143 20143.... 41 20143 20143.... 36 20143 20143.... 51 20146 20146.... 65 20146 20146.... 60 20146 20146.... 55 20146 20146 268

.... 48 20094 20094.... 50 19973 20054.... 52 200710 200710.... 50 19948 20084.... 36 19987 20081 4820037 1985198919891993 19941999 19992003 19857 AsiaPharm Biotech Pte. Ltd.Luye Biotech (Singapore) Pte. Ltd. A-Bio Pharma Pte. Ltd. 14 269

20037 5520037 19941980 199419941999 19992003 20032 49200731 200372000 19881994 1994 1999200019887 3320143 20098New Asia Partners Investment Holdings Limited 200412 20036 Luye Hong KongSolid SuccessApex Group Holdings 3820143 199872005 3 270

41201432009 1 002570 B2019956 201110EMBA 3620143 20054 20007 201392011120123 600873 5120146 1994151999620064 20089 20116 271

Yancoal Australia Ltd. YAL.... 20144 3380.... 201311 1290.... 201310 1819.... 20135 600280.... 20133 672.... 20131 8325.... 20129 656.... 20123 1685.... 201111 938.... 2011920124 272

198619911 6520146 2008 2007 2000 1093.... 20146 SVA.... 20063 726.... 20021201312 20134... 20101020133 20086 6020146 3020113 8020 20119 1999Emerging Markets Partnership (Hong Kong) Limited 273

798.... 20143 1886*... 20126 8020.... 201110 1132*... 20082 3398.... 200511 NTES*... 20027 758.... 20121220135 995.... 2005820118 * 197710 274

5520146 8001.... 20103 970.... 200710 1818.... 20075 1202.... 20062 2236.... 20121120139 20041020074 275

XV C.1. (a) 13.51(2) 4820094 2007 1120093DDI Asia/Pacific International Ltd19942007 LLY 19926 5019973 20052012 19839 1986919801983 200610 52200710 (Schwarz Pharma AG) 19911993 198271985719887 276

5019941999 20091988 199419887 20117 361998 15 KEDGE 22723D 9 3820143 15 277

300,000 300,000360,000300,000 201120122013 6.66.86.6 8 20141231 7.6 201120122013 201120122013 2.12.33.4 2014619 278

2014619 (i) (ii) (iii) 2014619 3A.19 3A.23 (a) (b) (c) (d) 13.10 13.46 279

5.65 3,592 20%718 20%718 280

20%718 20%718 5%180 5%180 2013123150 20131231 2.5% 28 10%360 5.92 3,7665.38 3,417 281

1,816.22,636.25.65 282

99,964,000 (i) (ii) 8 (a) (i) (ii) 283

(iii) (iv) (v) (vi) (vii) (viii) (ix) (x) (xi) (xii) 284

(xiii) (xiv) (xv) 32 (xvi) (xvii) (xviii) (1) (2) (3) (4) (b) (i) 285

(ii) (iii) (iv) (v) (vi) (vii) (viii) (ix) 286

(A) 10.0810.08 (B) 10.07(l)(a)(i) (ii) Shorea LBGGinkgo Trust LimitedNelumbo Investments Limited (a) (b) (a) (a) 10.07(2)(2) 10.07(2)(3)Shorea LBG Ginkgo Trust LimitedNelumbo Investments Limited (a) 10.07(2)(2) 287

(b) (A) (a) (b) (c) (a)(b) (d) (a)(b)(c) (a)(b)(c) (a)(b)(c) 288

(B) (a) (i) (ii) (iii) a(i)a(ii)(iv) a(i)a(ii)a(iii) a(i)a(ii)a(iii) (b) a(i)a(ii)a(iii) 289

(b) (c) (a)(b) (d) (a)(b)(c) (a)(b)(c) 2.6% 0.6% 30 149,946,000 15%1% 0.003%0.005% 291

5.65 179.8 CITICPE Holdings LimitedCPEChina CPEChina5%CPEChina 3A.07 CITICPE Holdings LimitedCPEChina CPEChina5%3A.07 CPEChina 292

(a) (b) 293

99,964,000 899,676,000 S 567,576,000332,100,000 149,946,000 30.1% 34.6% 99,964,00010% 3.0% 294

5,000,000 5,000,000 99,964,00050%49,982,000 99,964,00010% (i)1550(ii)50100(iii)100 299,892,000(i) 399,856,000 (ii)499,820,000(iii) 295

30%40%50% 899,676,000 567,576,000332,100,000 90% 27.1% S 144A 296

30 149,946,000 15% 30 201481 297

(a) (b)(i) (ii) (iii)(i)(ii) (iv) (v)(ii)(iii)(iv) 30 298

10.07(3) 10.07(1)(a)(i) (ii) 201472 201477 5.925.38 www.hkexnews.hkwww.luye.cn 299

20147 7 201478 5.925.38 5.921.0% 0.005%0.003%500 2,989.84 5.92 2014625 201472 300

30 201478 201479 201479 201479 500 301

eipo(www.eipo.com.hk) eipo 18 S eipo(i) (ii) eipo 302

www.eipo.com.hk 2014626201472 (1) 8 52 3 50 88 18 303

(2)... 193-209 341-343 B... 471 G13 L1 112-125 4851 611-617... G13-14 136 2014626201472 1992 2014626 2014627 2014628 2014630 201472 201472 304

eipo (a) (b) (c) (d) (e) (f) (g) (h) (i) 305

(j) (k) (l) (m) (n) (o) (p) (q) (r) (i) (ii) SS902(h)(3) eipo (s) (i) (ii) eipo eipo www.eipo.com.hk 306

eipo eipo eipo eipo 2014626201472 eipowww.eipo.com.hk24 201472 eipo eipo eipo eipo 40 40 342E eipo eipowww.eipo.com.hk 綠葉製藥集團有限公司 eipo 307

2979 7888 https://ip.ccass.com 199 (a) (b) 308

40 342E 309

500500 310

2014626 (1) 2014627 (1) 2014628 (1) 2014630 (1) 201472 (1) (1) 20146262014 7224 201472 40 40342E eipoeipo 311

eipo 201472(i)(ii) eipo 312

eipo500 500 www.eipo.com.hk 201472 201472 201478 www.luye.cnwww.hkexnews.hk 313

201478www.luye.cn www.hkexnews.hk 2014782014714 24www.iporesults.com.hk 2014782014711 2862 8669 2014782014710 (i) eipo eipo eipo 40 342E 314

(ii) eipo (iii) (iv) eipo 315

50% 5.92 201478 (i) (ii) 316

201478 201479 (a) 1,000,000 201478 183171712-1716 1,000,000 201478 (b) 1,000,000 1,000,000201478 201478 317

201478 (c) eipo 1,000,000 201478 183171712-1716 1,000,00020147 8 (d) 201478 318

201478 201478 201478 201478 319

1 22 綠葉製藥集團有限公司 II2.1 2011201220131231 2011201220131231 2014626 200372 II 11231 II 1 2011201220131231 I-1

3.340 2011201220131231 I-2

I. 1231 2011 2012 2013... 5 1,774,390 2,135,943 2,515,111.... (301,121) (351,813) (413,506)... 1,473,269 1,784,130 2,101,605... 5 25,934 12,717 35,902... (980,111) (1,209,717) (1,378,061).... (151,566) (157,906) (146,508).... (147,307) (145,522) (206,669).... 7 (19,636) (29,145) (24,091)... 19 545 894 990.... 6 201,128 255,451 383,168.... 10 (34,902) (79,862) (55,224).... 166,226 175,589 327,944... 155,752 169,032 310,498... 10,474 6,557 17,446 166,226 175,589 327,944... 13 31.61 34.30 63.01 12 I-3

1231 2011 2012 2013.... 166,226 175,589 327,944... (1,705) (133) 2,077.... 818 3,964 (3,953)... (887) 3,831 (1,876).... (887) 3,831 (1,876)... 165,339 179,420 326,068... 154,865 172,863 308,622... 10,474 6,557 17,446 165,339 179,420 326,068 I-4

1231 2011 2012 2013... 14 669,728 777,769 925,824... 22,853 29,912 48,948... 15 192,779 187,986 187,290... 16 347,356 347,356 347,356... 17 211,815 173,763 136,301... 19 3,652 4,749 5,323... 20 2,410 2,340 4,331... 1,292 792 292... 32 58,461 64,392 79,428... 1,510,346 1,589,059 1,735,093... 21 106,272 142,686 234,733.... 22 455,326 514,258 535,562.. 23 36,178 35,092 46,413... 40(b)(i) 3,755 12,212 314,209... 24 79,009 2,464 177,485... 20 10,000... 24 251,501 364,031 333,150 932,041 1,070,743 1,651,552... 25 17,825 818... 932,041 1,088,568 1,652,370.... 26 34,331 54,403 69,369.... 27 325,619 313,127 351,913... 28 453,815 444,863 735,921.... 30 28,310 45,218 74,436.... 32,010 26,589 34,488... 40(b)(ii) 4,902 36,856... 878,987 884,200 1,302,983... 53,054 204,368 349,387... 1,563,400 1,793,427 2,084,480 I-5

1231 2011 2012 2013... 28 2,000 25,924 9,387... 31 2,528.... 30 60,502 66,577 78,684... 32 93,983 117,119 98,714... 159,013 209,620 186,785... 1,404,387 1,583,807 1,897,695.... 33 81,180 81,180 81,180.... 427,980 427,980 427,980... 34 778,397 951,260 1,259,882 1,287,557 1,460,420 1,769,042.... 116,830 123,387 128,653... 1,404,387 1,583,807 1,897,695 I-6

* * * * * 34 201111... 81,180 427,980 41,387 121,355 466,745 1,873 (7,828) 1,132,692 115,491 1,248,183.... 155,752 155,752 10,474 166,226... (1,705) (1,705) (1,705).... 818 818 818... 155,752 (1,705) 818 154,865 10,474 165,339... 26,477 (26,477)... (9,135) (9,135) 20111231... 81,180 427,980 41,387 147,832 596,020 168 (7,010) 1,287,557 116,830 1,404,387 201211... 81,180 427,980 41,387 147,832 596,020 168 (7,010) 1,287,557 116,830 1,404,387.... 169,032 169,032 6,557 175,589... (133) (133) (133).... 3,964 3,964 3,964... 169,032 (133) 3,964 172,863 6,557 179,420... 25,399 (25,399) 20121231... 81,180 427,980 41,387 173,231 739,653 35 (3,046) 1,460,420 123,387 1,583,807 I-7

* * * * * 34 201311... 81,180 427,980 41,387 173,231 739,653 35 (3,046) 1,460,420 123,387 1,583,807.... 310,498 310,498 17,446 327,944... 2,077 2,077 2,077.... (3,953) (3,953) (3,953)... 310,498 2,077 (3,953) 308,622 17,446 326,068... 58,093 (58,093)... (12,180) (12,180) 20131231... 81,180 427,980 41,387 231,324 992,058 2,112 (6,999) 1,769,042 128,653 1,897,695 * 2011201220131231778,397,000952,260,0001,259,882,000 I-8

1231 2011 2012 2013.... 201,128 255,451 383,168... 19 (545) (894) (990).... 14 31,468 39,900 57,953... 17 42,676 38,877 37,629... 15 4,307 4,793 4,852... 500 500 500.. 336 2,138 430... 17 1,440.... 5 (4,823) (3,858) (3,030).... 7 19,285 28,662 23,955... 31 (1,621) 294,332 363,948 505,907... (99,041) (58,932) (21,304)... 23,419 5,001 5,814.. 806 (8,457) 568.... (9,170) (36,414) (92,047)... 29,759 13,583 15,885.... (9,301) 20,072 14,966.... 163,792 (35,936) 77,344.. 1,107 (4,902) 36,856... 395,703 257,963 543,989.... (22,821) (34,220) (26,360).... (59,462) (70,841) (78,003)... 313,420 152,902 439,626 I-9

1231 2011 2012 2013 (297,297) (146,240) (265,016)... 15 (39,592) (4,300)... 17 (1,341) (825) (1,607)... 20 (10,000)... 378 1,677 642... 35 (271,924) (3,000)... (13,662)... 10,503 9,400 25,440.... 40(b)(i) (302,565).... 5 4,823 3,858 3,030.... (608,112) (135,130) (554,376).... (448,729) (809,366) (1,023,915)... 627,336 824,338 1,298,436... 24 54,500 91,304 2,464... 24 (79,009) (14,759) (177,485)... (9,135) (12,180).... 144,963 91,517 87,320... (149,729) 109,289 (27,430)... 1,095 3,241 (3,451)... 24 400,135 251,501 364,031... 24 251,501 364,031 333,150 I-10

1231 2011 2012 2013... 18 116,135 116,135 116,135... 116,135 116,135 116,135... 40(b)(i) 9,445 174,780... 502,235 501,215 411,334.... 23 34,154 34,202 33,086... 24 2,202 5,602 215,745... 538,591 550,464 834,945... 28 - - 304,845... 139,831 167,705 164,479.... 27 2,099 1,637 1,789... 40(b)(ii) 4,110... 146,040 169,342 471,113... 392,551 381,122 363,832... 508,686 497,257 479,967... 508,686 497,257 479,967.... 33 81,180 81,180 81,180.... 427,980 427,980 427,980... 34 (474) (11,903) (29,193)... 508,686 497,257 479,967 I-11

II. 1. 綠葉製藥集團有限公司 200372 20045520121129 Clarendon House, 2 Church Street, Hamilton HM 11, Bermuda 137 Telok Ayer Street, #05-05, Singapore 068602 (a) AsiaPharm Biotech Pte. Ltd. ABPL(b) Luye Pharma Investments Pte. Ltd. Luye Pharma Investments(c) Luye Pharma Hong Kong Limited Luye Hong Kong Pacific Target Holdings Limited) (d) Solid Success Holdings Ltd. Solid Success(a) Kanghai Pharmaceutical Technology Development Limited Kang Hai(d) Apex Group Holding Limited Apex(d) A-Bio Pharma Pte. Ltd. A-Bio(b) Luye Biotech Pte. Ltd. Luye Biotech(b) 200372 1991423 2010826 2007731 2002822 2002622 1993610 2001817 2009116 % % 0.12 100 1.70 100 2 100 1 100 100 100 100 100 10,000 100 12.5 100 26.1 100 I-12

AsiaPharm Biotech Sdn. Bhd. AsiaPharm Biotech(m) (e) (f) Shandong Langhe Biotechnology Ltd. Shandong Langhe(f) Shandong Luye Natural Drug Research and Development Luye R&D(f) (g) (h) (i) Nanjing Kanghai Phospholipid Biological Technology Co., Ltd. Nanjing Kanghai Phospholipid(i) Shanghai Ge Lin Li Fu Consulting Co., Ltd. Shanghai Ge Lin(j) (k) Chengdu Bomai Technology Co., Ltd. Chengdu Bomai(l) Yantai Luye Pharma Holdings Co., Ltd. Yantai Luye 2010915 199468 1997327 2010311 20021231 2004222 199491 2010625 2010913 2010628 20001221 2004121 2014515 % % 100,000 100 271.8 100 20 100 10 100 5 100 70 100 80 69.55 0.3 100 1.5 100 1 100 36 100 0.5 100 73.6 100 I-13

(a) (b) (c) (d) (e) (f) (g) (h) (i) (j) (k) (l) (m) 50ABPLA-Bio Luye Biotech 50Luye Pharma InvestmentsStephen Koh & Co Luye Hong KongKang HaiAPEX Tony Kam & co. Luye R&DShangdong Langhe Nanjing Kanghai Phospholipid Shanghai Ge Lin Chengdu Bomai 1965 AsiaPharm BiotechEMC&Associates 2.1 201311 3 I-14

(i) (ii)(iii)(i) (ii)(iii) 2.2 9 3 9 9 7 739 3 39 10 12 27 11 1012 27 1 11 4 14 4 19 19 2 32 32 1 36 36 1 39 39 1 21 1 20102012 201312 2 20112013 201312 2 15 5 16 38 1638 4 1 201411 2 201471 3 4 201611 5 201711 2.3 I-15

(a) (b) (c) 5 20% 5 39 I-16

39 1231 I-17

(a) (b) (c) (d) I-18

I-19

(a)(b) I-20

(a) (b) I-21

I-22

5 I-23

1040 510 510 310 16%17%10% I-24

10 520 210 I-25

(a) (i) (ii) (iii) (b) (i) (ii) (iii) (iv) (v) (vi) (vii) (a) (a)(i) I-26

3. 2011201220131231 347,356,000347,356,000347,356,000 16 2011201220131231 58,461,000 64,392,00079,428,00032 I-27

2011201220131231 3,946,0005,682,0005,792,000 4. 2.3 20111231.... 799,921 613,926 280,038 80,505 1,774,390... 799,921 613,926 280,038 80,505 1,774,390.... 243,412 172,190 66,093 11,463 493,158... 25,934.... (151,566).... (147,307).... (19,636)... 545.... 201,128 I-28

20121231.... 940,830 630,654 451,086 113,373 2,135,943... 940,830 630,654 451,086 113,373 2,135,943.... 305,327 177,641 85,382 6,063 574,413... 12,717.... (157,906).... (145,522).... (29,145)... 894.... 255,451 20131231.... 1,102,165 723,079 575,237 114,630 2,515,111... 1,102,165 723,079 575,237 114,630 2,515,111.... 386,471 224,044 93,733 19,296 723,544... 35,902.... (146,508).... (206,669).... (24,091)... 990.... 383,168 (a) 1231 2011 2012 2013.... 1,754,182 2,116,486 2,495,120.... 20,208 19,457 19,991... 1,774,390 2,135,943 2,515,111 2011201220131231 10% I-29

(b) 1231 2011 2012 2013.... 1,441,128 1,516,657 1,645,478.... 8,347 5,670 5,856... 1,449,475 1,522,327 1,651,334 5. 1231 2011 2012 2013.... 1,801,411 2,173,332 2,557,215... 1,074 971 1,140 1,802,485 2,174,303 2,558,355.... (28,095) (38,360) (43,244) 1,774,390 2,135,943 2,515,111... 4,823 3,858 3,030.... 17,519 5,469 30,839.... 1,499 763 1,008... 2,093 2,627 1,025 25,934 12,717 35,902 I-30

6. 1231 2011 2012 2013.... 14 31,468 39,900 57,953 *... 17 42,676 38,877 37,629 **... 15 4,307 4,793 4,852 **... 500 500 500... 22 501 (1,253) 286... 23 3,009 (9)... 17,943 17,499 10,924.... 2,963 2,900 2,800 :.... 213,265 228,624 255,315... 33,013 40,116 46,084... 1,236 709 288... 18,805 18,700 24,880 266,319 288,149 326,567.... 134,906 134,368 194,081... 4,582 1,879 3,268... 2,300 5,536 6,199... 336 2,138 430... 2,971... 17 1,440... 2,212 1,601 1,251 147,307 145,522 206,669 1231 2011 2012 2013 ***... 300,471 351,527 413,264... 650 286 242... 17,453 19,739 39,807 *... 42,432 38,608 37,299.... 51,542 68,967 80,784 I-31

* ** *** 1,195,000584,0001,757,000 7. 1231 2011 2012 2013... 22,789 34,425 26,519... (3,536) (5,796) (2,596) 19,253 28,629 23,923.... 32 33 32... 19,285 28,662 23,955 31.... 139... 212 483 136 19,636 29,145 24,091 8. 161 1231 2011 2012 2013... 1,790 1,472 1,399.... 4,344 4,594 4,475... 473 731 675... 12 14 14 4,829 5,339 5,164 6,619 6,811 6,563 1231 2011 2012 2013 Tan Soo Kiat.... 337 327 321 Tan Chong Huat... 270 261 258 Hong Hai... 270 261 258 877 849 837 I-32

2011.... 239 2,601 257 4 3,101.... 188 950 130 4 1,272.... 162 793 86 4 1,045 589 4,344 473 12 5,418 Kung Kuo Chuan.... 162 162 Kong Teck Chien... 162 162 324 324 2012.... 232 2,723 429 5 3,389.... 182 1,016 170 4 1,372.... 157 855 132 5 1,149 571 4,594 731 14 5,910 Kung Kuo Chuan.... 26 26 Kong Teck Chien... 26 26 52 52 2013.... 228 2,715 367 5 3,315.... 179 1,118 200 4 1,501.... 155 642 108 5 910 562 4,475 675 14 5,726 9. 332 8223 1231 2011 2012 2013... 1,799 1,754 2,583... 272 545 841... 5 18 21 2,076 2,317 3,445 I-33

2011 2012 2013 1,000,0011,500,000... 2 2 3 10. 16.5% 17%25% 20081125% 15% 1231 2011 2012 2013... 73,313 57,599 87,053.... 25 5,058 1,612 32.... (38,436) 17,205 (33,441)... 34,902 79,862 55,224 I-34

1231 2011 2012 2013.... 201,128 255,451 383,168 25%... 50,282 63,863 95,792.... (1,804) 5,423 4,381... (25,020) (29,483) (37,661).... (3,610) (7,847) (9,681)... 3,036 520 584... 25 5,058 1,612 10%... 30,866... 4,960 6,039 5,963... (1,781) (1,062) (2,196).... (3,841)... 8,814 6,485 271... 34,902 79,862 55,224 20112012201317.4%31.3%14.4% 11. 2011201220131231 12,624,00010,714,000820,000 34 12. 13. 1231 2011 2012 2013.... 155,752 169,032 310,498 2011 2012 2013... 492,764,900 492,764,900 492,764,900 I-35

14. 20111231 201111... 148,637 205,386 12,143 31,125 67,365 464,656... (30,139) (103,327) (2,508) (9,285) (145,259)... 118,498 102,059 9,635 21,840 67,365 319,397 201111... 118,498 102,059 9,635 21,840 67,365 319,397 35 25,829 15,497 2,334 3,075 510 47,245... 3,315 16,237 2,730 10,167 302,819 335,268... (327) (269) (118) (714)... (6,618) (17,940) (1,949) (4,961) (31,468)... 797 686 (1,483) 20111231.. 141,821 116,212 12,481 30,003 369,211 669,728 20111231... 178,578 233,304 15,581 42,691 369,211 839,365... (36,757) (117,092) (3,100) (12,688) (169,637)... 141,821 116,212 12,481 30,003 369,211 669,728.. 1,267 81,312 3,157 19,912 105,648 20121231 20111231 201211... 178,578 233,304 15,581 42,691 369,211 839,365... (36,757) (117,092) (3,100) (12,688) (169,637)... 141,821 116,212 12,481 30,003 369,211 669,728 201211 141,821 116,212 12,481 30,003 369,211 669,728... 1,928 38,542 640 6,383 122,783 170,276... (232) (1,591) (1,688) (304) (3,815)... (8,837) (24,298) (1,980) (4,785) (39,900) (11,894) (6,626) (18,520)... 256,310 114,269 3,990 (374,569) 20121231.. 390,990 231,240 9,453 28,661 117,425 777,769 I-36

20121231... 436,330 366,051 13,802 41,430 117,425 975,038... (45,340) (134,811) (4,349) (12,769) (197,269)... 390,990 231,240 9,453 28,661 117,425 777,769.. 1,581 82,902 3,361 19,763 107,607 20131231 20121231 201311... 436,330 366,051 13,802 41,430 117,425 975,038... (45,340) (134,811) (4,349) (12,769) (197,269)... 390,990 231,240 9,453 28,661 117,425 777,769 201311... 390,990 231,240 9,453 28,661 117,425 777,769... 3,295 25,104 5,196 6,981 169,251 209,827... (2) (761) (191) (118) (1,072)... (15,685) (34,769) (2,027) (5,472) (57,953)... (2,747) (2,747)... 78,017 189,004 6,299 (273,320) 20131231.. 456,615 407,071 12,431 36,351 13,356 925,824 20131231... 517,640 556,549 17,254 53,866 13,356 1,158,665... (61,025) (149,478) (4,823) (17,515) (232,841)... 456,615 407,071 12,431 36,351 13,356 925,824.. 1,907 98,517 3,770 22,035 126,229 20112012201312311,704,000 208,609,000275,252,000 I-37

15. 1231 2011 2012 2013 11... 151,709 194,647 189,854 35.... 7,653... 39,592 4,300... (4,307) (4,793) (4,852) 1231... 194,647 189,854 189,302... (1,868) (1,868) (2,012).... 192,779 187,986 187,290 16. 1231 2011 2012 2013 11.... 188,212 347,356 347,356 35.... 159,144 1231... 347,356 347,356 347,356 (a) (b) (c) Solid Success GroupSSL (d) ABPLHypocol (e) (f) I-38

2011 2012 2013.... 38,444 38,444 38,444... 5,954 5,954 5,954 SSL... 114,185 114,185 114,185 ABPL... 7,353 7,353 7,353... 22,276 22,276 22,276... 159,144 159,144 159,144... 347,356 347,356 347,356 2011201220131231 14%14%15%3% I-39

17. 20111231 201111.... 10,833 304,080 1,355 316,268... (6,150) (121,047) (280) (127,477).... 4,683 183,033 1,075 188,791 201111... 4,683 183,033 1,075 188,791 35.... 31,185 31,646 148 1,380 64,359... 381 960 1,341... (2,258) (40,174) (244) (42,676) 20111231... 33,610 174,505 1,360 2,340 211,815 20111231 201211.... 42,018 335,726 1,884 2,340 381,968... (8,408) (161,221) (524) (170,153).... 33,610 174,505 1,360 2,340 211,815 20121231 201211... 33,610 174,505 1,360 2,340 211,815... 825 825... (3,040) (35,568) (269) (38,877) 20121231... 30,570 138,937 1,916 2,340 173,763 20121231 201311.... 42,018 335,726 2,709 2,340 382,793... (11,448) (196,789) (793) (209,030).... 30,570 138,937 1,916 2,340 173,763 20131231 201311... 30,570 138,937 1,916 2,340 173,763... 1,607 1,607... (1,440) (1,440)... 900 (900)... (3,066) (34,233) (330) (37,629) 20131231... 27,504 105,604 3,193 136,301 20131231.... 41,971 336,626 4,316 382,913... (14,467) (231,022) (1,123) (246,612).... 27,504 105,604 3,193 136,301 I-40

18. 1231 2011 2012 2013... 116,135 116,135 116,135 2011201220131231 502,235,000501,215,000411,334,000 139,831,000167,705,000164,479,000 19. 1231 2011 2012 2013... 1,947 2,037 1,914 11.... 3,313 3,652 4,749.... 545 894 990... (206) 203 (416) 3,652 4,749 5,323 2011201220131231 Steward Cross Pte. Ltd.* Steward Cross 620,002 36 * 1231 2011 2012 2013.... 21,572 21,495 22,111.... 10,855 8,867 6,169 1231 2011 2012 2013... 53,272 47,521 45,367... 1,514 2,483 2,750 I-41

20. 1231 2011 2012 2013... 10,000.... 1,910 1,840 3,831... 500 500 500 2,410 2,340 4,331 (a)(b) 21. 1231 2011 2012 2013... 34,039 50,901 95,854... 40,503 53,883 81,523... 31,730 37,902 57,356 106,272 142,686 234,733 22. 1231 2011 2012 2013... 313,792 339,525 393,459.... 144,880 176,806 144,295 458,672 516,331 537,754... (3,346) (2,073) (2,192) 455,326 514,258 535,562 I-42

201111... 870 1,869 2,739... 267 267.... 1,275 209 1,484... (983) (983)... (161) (161) 20111231201211... 2,251 1,095 3,346.... 679 679... (1,876) (56) (1,932)... (20) (20) 20121231201311... 355 1,718 2,073.... 1,256 253 1,509... (73) (1,150) (1,223)... (167) (167) 20131231... 1,538 654 2,192 1231 2011 2012 2013.... 268,824 311,934 370,021.... 36,622 12,316 18,139... 4,009 9,956 2,346.... 2,570 3,743 813.... 1,767 1,576 2,140 313,792 339,525 393,459 1231 2011 2012 2013... 246,049 315,009 386,232... 52,710 10,401 2,817... 11,687 12,042 2,218 310,446 337,452 391,267 2011123165,147,000 57,310,00028 201220131231 I-43

2012201312314,209,0004,555,000 4,209,0004,555,000 26 20131231 73,168,000213,392,000 28 20111231 201120121231 4,890,0007,738,00028 20131231 23. 1231 2011 2012 2013... 18,138 19,379 30,749.... 2,023 2,763.... 14,676 16,401 19,096.... 1,941 158 168 36,778 38,701 50,013... (600) (3,609) (3,600) 36,178 35,092 46,413 1231 2011 2012 2013... 11.... 381 500 406.... 33,773 33,691 32,680 34,154 34,202 33,086... 34,154 34,202 33,086 201111... 600... 20111231201211... 600.... 3,009... 20121231201311... 3,609....... (9) 20131231... 3,600 I-44

1231 2011 2012 2013... 36,178 35,092 46,413 24. 1231 2011 2012 2013... 231,501 364,031 333,150.... 99,009 2,464 177,485 330,510 366,495 510,635... (9,347)... (79,009) (2,464) (168,138)... 251,501 364,031 333,150... 219,267 325,386 96,070.... 27,628 29,800 221,103... 4,606 8,845 15,977... 251,501 364,031 333,150 1231 2011 2012 2013... 2,202 5,602 215,745.... 753 1,013 214,250... 1,449 4,589 1,495... 2,202 5,602 215,745 201120122013123179,009,0002,464,000 163,605,00028 I-45

201312314,533,00026 25. 1231 2011 2012 2013... 17,825 818 2012725A-BioPrime Biologics Private Limited Prime3,500,00017,825,000 20121231Prime18,975,00020121231 1,150,00020131 Prime 20131231 2,747,0001,929,000 20131231 26. 1231 2011 2012 2013... 34,331 50,049 56,266.... 4,354 13,103 34,331 54,403 69,369 1231 2011 2012 2013.... 25,007 44,436 66,073.... 8,076 7,507 2,023... 996 2,021 765.... 156 310 142.... 96 129 366 34,331 54,403 69,369 90 2012201312314,209,0004,555,000 4,209,0004,555,00022 2013123113,103,0004,533,000 24 I-46

27. 1231 2011 2012 2013... 90,149 40,150 48,869.... 60,656 55,862 82,497.... 39,575 52,187 59,440.... 20,595 10,765 16,602 35.... 3,000.... 37,515 36,828 65,919... 74,129 117,335 78,586 325,619 313,127 351,913 1231 2011 2012 2013.... 1,265 405 1,061.... 834 1,232 728 2,099 1,637 1,789 28. 2011 (%) 50,000... 6.1 2012326 50 450,000............ 6.1 2012529 450 3,310,00022... 7.544 201267 3,310 5,000,000.... 7.015 2012626 5,000 10,000,000.... 5.81 2012119 10,000 10,000,000.... 6.63 2012526 10,000 10,000,000.... 7.872 2012728 10,000 10,000,000.... 7.216 2012929 10,000 10,000,000.... 6.56 2012119 10,000 19,000,00022.. 6.1425 2012224 19,000 20,000,000.... 6.405 201268 20,000 20,000,000.... 7.872 201289 20,000 20,000,000.... 7.216 2012929 20,000 20,000,000.... 7.216 2012929 20,000 25,000,000.... 6.405 201235 25,000 29,000,000.... 6.63 2012519 29,000 30,000,000.... 5.5195 2012120 30,000 30,000,000.... 6.63 2012519 30,000 30,000,000.... 6.31 201268 30,000 I-47

(%) 35,000,00022.. 6.405 201261 35,000 100,000,000.... 7.872 2012818 100,000 10,000,000.... 7.544 20121122 10,000 4,890,00022... 8.7 2012110 4,890 29.... 1.622 2015109 2,115 453,815 29.... 1.622 2015109 747 29.... 2.2 2020830 1,253 2,000 455,815 2012 (%) 20,000,000.... 6.72 2013115 20,000 50,000,000.... 6.60 2013927 50,000 20,000,000.... 6.00 20131019 20,000 50,000,000.... 4.00 201355 50,000 10,000,000.... 5.60 20131114 10,000 10,000,000.... 5.60 201367 10,000 30,000,000.... 6.56 2013213 30,000 10,000,000.... 6.56 2013120 10,000 2,000,000.... 6.89 2013215 2,000 79,000,000.... 6.06 2013118 79,000 21,000,000.... 6.06 20131118 21,000 4,700,000.... 6.94 2013611 4,700 3,723,000.... 7.315 2013128 3,723 3,785,000.... 7.315 2013428 3,785 3,849,000.... 7.315 2013728 3,849 3,915,000.... 7.315 20131028 3,915 10,000,000.... 5.88 2013227 10,000 10,000,000.... 5.88 2013228 10,000 25,000,000.... 5.88 201364 25,000 20,000,000.... 5.88 201351 20,000 30,000,000.... 6.00 2013929 30,000 20,000,000.... 5.60 2013226 20,000 2,280,00022... 5.59 201358 2,280 5,012,00022... 6.44 2013311 5,012 446,00022.... 6.00 2013125 446 29.... 2.2 2020830 153 444,863 24,918,000.... 7.315 2015428 24,918 29.... 2.2 2020830 1,006 25,924 470,787 I-48

2013 (%) 20,000,000.... 5.6 2014211 20,000 20,000,000.... 6.0 2014514 20,000 29,000,000.... 6.0 2014213 29,000 30,600,000.... 5.88 2014520 30,600 10,000,000.... 5.5 2014110 10,000 60,000,000.... 5.66 2014528 60,000 20,000,000.... 5.6 2014213 20,000 10,000,000.... 5.6 201457 10,000 30,000,000.... 5.6 201463 30,000 10,000,000.... 5.6 2014116 10,000 10,000,000.... 5.6 2014225 10,000 10,000,000.... 5.6 2014225 10,000 40,000,000.... 5.66 2014328 40,000 20,000,000.... 5.5 201418 20,000 25,000,000.... 5.55 2014321 25,000 30,000,000.... 5.55 2014120 30,000 20,000,000.... 5.6 2014423 20,000 3,981,000.... 6.765 2014128 3,981 4,048,000.... 6.765 2014428 4,048 4,117,000.... 6.765 2014728 4,117 4,186,000.... 6.765 20141028 4,186 15,000,000... 3 20141220 91,453 91,453 +2.2 35,000,000 22.... 20141215 213,392 213,392 3 +2.2 20,000,000.... 5.6 2014215 20,000 29.... 2.2 2020830 144 735,921 304,845 8,586,000.... 6.765 2015428 8,586 29.... 2.2 2020830 801 9,387 745,308 304,845 1231 2011 2012 2013... 453,815 444,863 735,921.... 893 16,471 8,715.... 584 9,085 462.... 523 368 210 455,815 470,787 745,308 2011 2012 2013... 304,845 304,845 I-49

(i) 201120122013123179,009,000 2,464,000163,605,00024 (ii) 2011123165,147,00022 (iii) 2013123173,168,00022 29. 2011 2012 2013 2011 2012 2013.... 2,195 186 175 2,115 153 144.... 973 186 175 893 139 129.... 770 558 525 584 499 462.... 638 484 278 523 368 210... 4,576 1,414 1,153 4,115 1,159 945... (461) (255) (208)... 4,115 1,159 945 28.... (2,115) (153) (144) 28.... 2,000 1,006 801 I-50

30. 2011 2012 2013 11.... 48,550 88,812 111,795... 53,599 28,373 60,334.... (13,337) (5,390) (19,009) 1231.... 88,812 111,795 153,120... 28,310 45,218 74,436... 60,502 66,577 78,684 88,812 111,795 153,120 31. 1231 2011 2012 2013 11.... 2,389 2,528.... (1,621) 7.... 139.... (907) 1231.... 2,528 2012 2012 32. 1231 2011 2012 2013... 58,461 64,392 79,428... (93,983) (117,119) (98,714) (35,522) (52,727) (19,286) I-51

2011 20101231 201111... 10,358 1,465 189 929 2,138 7,847 22,926 (47,148) (34,390) (81,538) 35.... 3,741 3,741 (21,175) (21,175) 10.... 7,690 (495) 165 (438) 8,371 16,501 31,794 6,642 6,642 38,436... 2,088 2,088 20111231... 21,789 970 354 491 10,509 24,348 58,461 (61,681) (32,302) (93,983) 2012 20111231 201211... 21,789 970 354 491 10,509 24,348 58,461 (61,681) (32,302) (93,983) 10.... 547 (239) (25) 361 3,373 1,914 5,931 7,730 (30,866) (23,136) (17,205) 20121231... 22,336 731 329 852 13,882 26,262 64,392 (53,951) (63,168) (117,119) 2013 20121231 201311... 22,336 731 329 852 13,882 26,262 64,392 (53,951) (63,168) (117,119) 10.... 13,178 (477) 289 955 14 5,597 (4,520) 15,036 9,405 9,000 18,405 33,441 20131231... 35,514 254 289 1,284 866 19,479 21,742 79,428 (44,546) (54,168) (98,714) I-52

10% 20081120071231 10% 2008112011 201220131231 323,020,000631,680,000 541,680,000201120122013123110% 32,302,00063,168,00054,168,000201120122013 1231 357,537,000302,816,000586,826,000 201120122013123154,807,000 67,287,00052,399,000 20112012201312311,755,823 8,673,0004,518,000 33. 1231 2011 2012 2013 5,000,000,0000.02... 100,000 100,000 100,000.... 828,650 828,650 828,650 492,764,9000.02... 9,855 9,855 9,855.... 81,180 81,180 81,180 34. 10%50% 25% I-53

201111... (94,242) 121,674 27,432... (12,624) (12,624).... (15,282) (15,282) 20111231... (109,524) 109,050 (474)... (10,714) (10,714).... (715) (715) 20121231... (110,239) 98,336 (11,903)... (820) (820).... (16,470) (16,470) 20131231... (126,709) 97,516 (29,193) 35. 2011 201171 288,000,000 14.... 46,735 14.... 510.... 10,807 17.... 64,359 15.... 7,653... 22,933.... 34,858... 19,260... 13,076 32.... 3,741... (11,750)... (23,336).... (38,815) 32.... (21,175)... 128,856 16.... 159,144... 288,000 I-54

.... 285,000 27.... 3,000... 288,000.... 288,000... (3,000)... 285,000... (13,076)... 271,924 20111231 82,650,9885,027,629 20111231 1,833,476,000149,753,000 20122013 36. 1231 2011 2012 2013.... 30.45% 30.45% 30.45% 1231 2011 2012 2013.... 79,871 90,556 99,397.... 14,602 10,685 21,021.... 9,135 12,180 I-55

2011 2012 2013... 325,870 263,280 314,916.... (57,413) (67,635) (90,783).... (147,074) (110,031) (101,597).... (41,767) (21,300) (22,035)... 5,114 3,279 2,034.... (27,979) (27,592) (22,629).... 56,751 40,001 79,906... (8,798) (4,911) (10,873).... 47,953 35,090 69,033... 47,953 35,090 69,033... 14,602 10,685 21,021.... 9,135 12,180 1231 2011 2012 2013.... 200,350 202,596 189,842.... 141,161 173,334 198,504.... (71,709) (65,348) (48,232).... (7,500) (13,190) (13,689)... 262,302 297,392 326,425... 182,431 206,836 227,028... 79,871 90,556 99,397 1231 2011 2012 2013... 24,975 (7,405) 53,830... (48,098) (22,721) (46,462)... (9,135) (61,312).... (475) (27) (285).... (32,733) (30,153) (54,229) I-56

37. 1231 2011 2012 2013... 59,462 70,841 69,003... 9,000 59,462 74,541 78,003 38. 2011 201220131231 1231 2011 2012 2013... 4,554 3,461 4,267.... 7,850 5,500 4,419... 2,700 12,404 8,961 11,386 39. 38 1231 2011 2012 2013 *... 57,726 43,331 138,952... 40,955 63,228 41,906 98,681 106,559 180,858 * 20131231105,863,00040(a) (iii) I-57

40. Steward Cross AsiaPharm (Singapore) Pte. Ltd. AsiaPharm Singapore AsiaPharm Singapore (a) 1231 2011 2012 2013.... (i) 5,622 4,870 6,609.... (ii) 6,181 302,565 AsiaPharm Singapore... (ii) 1,698 321.... (ii) 653... (iii) 12,000.... 953... 36,000 (i) Steward Cross (ii) (iii) 20131220 117,863,00020131231 12,000,000105,863,000 39 I-58

(b) (i) 1231 2011 2012 2013 Steward Cross... 3,755 3,647 2,253 AsiaPharm Singapore... 1,698 2,019.... 653 206.... 6,181 308,746.... 33 32... 12,953 3,755 12,212 326,209 1231 2011 2012 2013 AsiaPharm Singapore... 2,578 2,019.... 653 205.... 6,181 172,524.... 33 32 9,445 174,780 (ii) 1231 2011 2012 2013.... 2,898 AsiaPharm Singapore... 2,004 856... 36,000 4,902 36,856 1231 2011 2012 2013.... 2,898 AsiaPharm Singapore... 1,212 4,110 I-59

(c) 1231 2011 2012 2013... 14,183 13,507 14,010... 114 88 99... 14,297 13,595 14,109 8 41. 2011... 2,410 2,410.... 455,326 455,326.... 18,138 18,138... 251,501 251,501... 79,009 79,009... 3,755 3,755 807,729 2,410 810,139.... 34,331 34,331... 167,278 167,278... 455,815 455,815... 2,898 2,898... 2,004 2,004 662,326 662,326 I-60

2012... 2,340 2,340.... 514,258 514,258.... 19,379 19,379... 364,031 364,031... 2,464 2,464... 12,212 12,212 912,344 2,340 914,684.... 54,403 54,403... 157,485 157,485... 470,787 470,787 682,675 682,675 2013... 14,331 14,331.... 535,562 535,562.... 30,749 30,749... 333,150 333,150... 177,485 177,485... 313,256 313,256 1,390,202 14,331 1,404,533 I-61

.... 69,369 69,369... 127,455 127,455... 745,308 745,308... 856 856 942,988 942,988 2011... 2,202 2,202... 502,235 502,235 504,437 504,437... 4,110 4,110... 139,831 139,831 143,941 143,941 2012... 5,602 5,602... 9,445 9,445... 494,411 494,411... 11 11 509,469 509,469 I-62

... 160,901 160,901 160,901 160,901 2013... 215,745 215,745... 174,780 174,780... 411,334 411,334 801,859 801,859... 304,845 304,845... 164,479 164,479 469,324 469,324 39 20 201339,167,880 11,240,00057,100,000 70,100,000 2013 1231 I-63

2011201220131231 201120122013123154,614,000 18,389,00073,620,0002011201220131231 33,779,0007,081,00056,064,000 20,835,00011,308,000 17,556,000 42. 20111231.... 1,910 1,910 20121231.... 1,840 1,840 I-64

20131231.... 3,831 3,831.. 10,000 10,000 13,831 13,831 2011201220131231 43. 30%80% I-65

2011... 50 (64)... (50) 64 2012... 50 (26)... (50) 26 2013... 50 (33)... (50) 33... 50 (36)... (50) 36 I-66

% 2011... 5 550... (5) (550)... 5 681... (5) (681) 2012... 5 1,963... (5) (1,963)... 5 (6)... (5) 6.... 5 308.... (5) (308)... 5 27... (5) (27) 2013... 5 5,017... (5) (5,017)... 5 6,806... (5) (6,806).... 5 1,272.... (5) (1,272)... 5 21... (5) (21) 2223 I-67

2011201220131231 20111231... 38,848 425,526 2,965 638 467,977.... 25,007 9,072 252 34,331... 164,278 3,000 167,278... 4,902 4,902 4,902 228,133 437,598 3,217 638 674,488 20121231... 108,270 332,565 45,107 485,942.... 11,283 43,120 54,403... 21,539 135,946 157,485 32,822 287,336 332,565 45,107 697,830 20131231... 274,878 476,405 9,589 760,872.... 10,483 58,886 69,369... 51,926 75,529 127,455... 856 856 63,265 409,293 476,405 9,589 958,552 I-68

2011201220131231 20111231... 2,898 2,898... 1,212 1,212... 139,831 139,831 143,941 143,941 20121231... 160,901 160,901 160,901 160,901 20131231... 1,305 310,712 312,017... 164,479 164,479 164,479 1,305 310,712 476,496 2011201220131231 I-69

30% 2011 2012 2013... 455,815 470,787 745,308.... 34,331 54,403 69,369.... 325,619 313,127 351,913... 4,902 36,856... (251,501) (364,031) (333,150)... (79,009) (2,464) (177,485).... 490,157 471,822 692,811... 1,287,557 1,460,420 1,769,042.... (168) (35) (2,112).... 1,287,389 1,460,385 1,766,930... 1,777,546 1,932,207 2,459,741... 28% 24% 28% 44. 2014515Yantai luye Pharma Holdings Co., Ltd. 30,000,000201466Yantai Luye Pharma Holdings Co., Ltd.43,590,000Yantai Luye Pharma Holdings Co., Ltd. 30,000,00073,590,000 201453052,865,878 324,339,000200,000,00051,932,992 45. 20131231 綠葉製藥集團有限公司 2014626 I-70

A. 4.29 20131231 20131231 20131231 20131231 2013 1231 1 2 34 5.38... 1,285,385 2,737,347 4,022,732 1.51 5.92... 1,285,385 3,016,824 4,302,209 1.62 II-1

(1) 20131231.... 1,897,695... (128,653).... (347,356)... (136,301)... 1,285,385 (2) 5.385.92 (3) 3,321,073,8431.000.8010 (4) 20145 52,865,878324,339,000 51,932,992200,000,000 1.325.38 1.42 5.92 (5) 20131231 II-2

B. 1 22 綠葉製藥集團有限公司綠葉製藥集團有限公司 II-1201312 31 (A)15 2013 123120131231 20131231 4.29 7 4.29(7) II-3

3420 4.29 7 II-4

(a) (b) (c) 4.29(1) 2014626 II-5

1. 42A 2. 2014619 (a) (i) III-1

(ii) (iii) (iv) (v) (vi) III-2

(aa) (bb) (cc) III-3

(dd) (ee) (vii) III-4

(viii) (14) III-5

(ix) (b) (c) (i) (ii) (iii) III-6

(iv) (v) (vi) (vii) (d) (e) (21)(10) (95%) (21)(10) III-7

(f) (g) (h) III-8

(21) (i) (21) (20)(e) (21)(10) III-9

(14)(10) (j) III-10

(30) (k) (l) (m) (i) (ii) (a) (b) III-11

(n) (o) (20%) (14) III-12

(20%) (p) (q) (r) 4(e) (s) (t) (i) (ii) III-13

(iii) (u) 3. (21) 95%(21) 4. (a) III-14

(i) (ii) (aa) (bb) (iii) (b) (c) III-15

(i)(ii) (iii)(i)(ii) 42A (d) (i)(ii) 54 (e) III-16

(f) (g) (i) (ii)(iii) III-17

(5) (21) (7) (h) (21) III-18

(7) (15) (i) (j) 2035331 III-19

(k) (l) (20%)(a) (b) (c)98(2)(c) (m) (2) (14) III-20

(2)87A (n) III-21

5. Conyers Dill & Pearman III-22

A. 1. 200372 15 8201442862216 15 8 2. (a) 201453051,932,992 200 (b) 20146195,000,000,000 100,000,000200,000,000 3. 2014619 (a) (b) 5,000,000,000100,000,000 200,000,000 (c) 44,254,038.70 IV-1

2,212,701,935 (d) (i) (ii) (e) 20%(g) (f) 10% (g) (f) (e)(f)(g) IV-2

4. 1 (a) (b) (c) (d) 2012925271,800,000 201433622Luye Hong KongApex Group HoldingsKang Hai Pharmaceutical 622135Luye Hong Kong Apex Group HoldingsKang Hai Pharmaceutical Luye Hong Kong11.00 Apex Group Holdings10,00010,000.00 Kang Hai Pharmaceutical100100.00 2014515Yantai Luye Pharma Holdings Co. Ltd. Yantai Luye Pharma Holdings Co. Ltd. 201466Yantai Luye Pharma Holdings Co., Ltd.Yantai Luye Pharma Holdings Co., Ltd. 43,590,000Yantai Luye Pharma Holdings Co., Ltd. 73,590,000 5. (a) (i) IV-3

2014619 10% (i) (ii) (iii) (ii) (iii) 10% 30 5% IV-4

(iv) (v) (a) (b) (vi) 30 (vii) (b) IV-5

20145302 51,932,9923.85 B. 1. (a) (b) (c) (d) (e) (f) A-Bio Pharma Pte. Ltd.PrIME Biologics Private Limited 20127253.5 A-Bio Pharma Pte. Ltd. 20131220 117,863,262 2014165 2014324 50,000 Yantai Luye Pharma Holdings Co. Ltd.2014526 Yantai Luye Pharma Holdings Co., Ltd.Yantai Luye Pharma Holdings Co. Ltd.43,590,000 Citigroup Global Markets Limited 2014620 25500 IV-7

(g) (h) (i) (j) (k) (l) (m) (n) TAL China Focus Master Fund Citigroup Global Markets Limited 20146 20TAL China Focus Master Fund 30500 Citigroup Global Markets Limited 20146 20 100500 Citigroup Global Markets Limited 20146 20 25500 OrbiMed Advisors LLC Citigroup Global Markets Limited 2014620 OrbiMed Advisors LLC 50500 Dragon Billion China Master FundLMA SPC Citigroup Global Markets Limited 2014620Dragon Billion China Master FundLMA SPC47,747,301 2,252,699500 2014619 2014620 IV-8

C. 1. (a) XV XV78 352 (%) (1) 1,509,819,930 45.4% (1) Shorea LBGGinkgo Trust LimitedNelumbo Investments Limited 1,509,819,930Nelumbo Investments Limited 70% (%) (1) Shorea LBG 100% Ginkgo Trust Limited 100% Nelumbo Investments Limited 100% (2) 70% IV-9

(%) (2) 15% (2) 15% 100% 100% 100% (1) Nelumbo Inventments LimitedGinkgo Trust Limited (2) (b) 2. D. 1. 2. 3. IV-10

1,000,0001.007.761 7,761,000 4. Conyers Dill & Pearman 16 7 12 45 6 7 14 6 5. 44A44B 6. 32L4 IV-11

7. 32L 6(2) 34(2)342(1)(b) 8. 12,000 9. (a) (i) (ii) (b) (i) (ii) (iii) (c) B.1. IV-12

10. PO Box 309, Ugland House, Grand Cayman, KYI-1104, Cayman Islands 33,210,000 49,820,000 Beyond Border 3rd Floor, 18 Fort Street, George Town, Grand Cayman, KYI-1104, Cayman Islands 66,096,589 22,141,882 CDH Flower 1 1503 78,114,151 26,167,678 CPE Greenery PO Box 309, Ugland House, Grand Cayman, KYI-1104, Cayman Islands 82,573,890 27,661,660 Tropical Excellence 168 Robinson Road, #37-01 Capital Tower, Singapore 068912 72,105,370 24,154,780 IV-13

附錄六知識產權商標於中國註冊的商標截至最後實際可行日期我們已於中國註冊下列我們認為對業務重要或可能屬重要的商標商標註冊號類別註冊擁有人有效期 1038602 5 山東綠葉 2007年6月28日 2017年6月27日 9997380 5 山東綠葉 2012年11月21日 2022年11月20日 1770615 5 山東綠葉 2012年5月21日 2022年5月20日 1616597 5 山東綠葉 2011年8月14日 2021年8月13日 1320277 5 山東綠葉 2009年10月7日 2019年10月6日 1410387 5 山東綠葉 2010年6月21日 2020年6月20日 1425378 5 山東綠葉 2010年7月28日 2020年7月27日 3148088 5 山東綠葉 2013年6月14日 2023年6月13日 3344211 5 山東綠葉 2004年5月7日 2014年5月6日* 3739839 5 山東綠葉 2006年5月7日 2016年5月6日 7533236 44 山東綠葉 2011年3月14日 2021年3月13日 7533238 5 山東綠葉 2010年12月28日 2020年12月27日 7533239 10 山東綠葉 2011年3月14日 2021年3月13日 7533237 5 山東綠葉 2011年6月14 2021年6月13日 5131489 5 北大維信 2010年7月28日 2020年7月27日 1002799 5 北大維信 2007年5月14日 2017年5月13日 1111681 5 北大維信 2007年9月28日 2017年9月27日 3334906 5 北大維信 2004年5月7日 2014年5月6日* 3448199 5 北大維信 2004年10月21日 2014年10月20日* 5112359 5 北大維信 2011年2月28日 2021年2月27日 6174120 5 北大維信 2010年2月28日 2020年2月27日 6288792 5 北大維信 2010年4月28日 2020年4月27日 8375562 5 北大維信 2011年6月21日 2021年6月20日 870065 5 南京綠葉思科 2006年9月14日 2016年9月13日 3598965 5 南京綠葉思科 2005年7月21日 2015年7月20日 7172875 5 四川綠葉 2010年8月14日 2020年8月13日 VI-1

附錄六商標知識產權註冊號類別註冊擁有人有效期 3963840 5 四川綠葉 2006年8月28日 2016年8月27日 3080426 5 四川綠葉 2013年3月21日 2023年3月20日附註 * 我們擬於或已經於該等商標註冊到期前申請續期於中國境外註冊的商標截至最後實際可行日期我們已於中國境外註冊下列我們認為對業務重要或可能屬重要的商標商標註冊地註冊號註冊擁有人有效期香港 302710494 山東綠葉 2013年8月20日 2023年8月19日 CADIAESCIN 巴基斯坦 232313 山東綠葉 2007年2月7日 2017年2月7日 CMNa 巴基斯坦 239635 山東綠葉 2007年7月28日 2017年7月28日 CMNa 韓國 732925 山東綠葉 2008年1月2日 2018年1月2日 SALUTA 菲律賓 4-2007500406 山東綠葉 2008年5月5日 2018年5月5日 Âêßñçíì 俄羅斯 376010 山東綠葉 2008年1月16日 2018年1月16日 GLATION 俄羅斯 376009 山東綠葉 2008年1月16日 2018年1月16日 GSH 蒙古 8023 山東綠葉 2010年1月6日 2020年1月6日澳大利亞美國歐盟日本俄羅斯韓國新加坡土耳其 1033791 山東綠葉 2009年11月10日 2019年11月10日菲律賓 4-2009011118 山東綠葉 2010年5月6日 2020年5月6日馬來西亞 09021485 山東綠葉 2009年12月7日 2019年12月7日百慕達 49455 山東綠葉 2009年12月3日 2016年12月3日 VI-2

附錄六商標知識產權註冊地註冊號註冊擁有人有效期越南 186597 山東綠葉 2011年1月18日 2021年1月18日台灣 01611211 山東綠葉 2013年12月1日 2023年11月30日 WPU 香港 301687807 北大維信 2010年8月12日 2020年8月11日 XZK 香港 301687816 北大維信 2010年8月12日 2020年8月11日㹶㜸ᓭ 香港 300805833 北大維信 2007年1月29日 2017年1月28日香港 300805824 北大維信 2007年1月29日 2017年1月28日 XUEZHIKANG 香港 300805842 北大維信 2007年1月29日 2017年1月28日 Xuezhikang 香港 2002B04609 北大維信 2007年7月10日 2017年7月10日㹶㜸ᓭ 澳門 027057 北大維信 2007年10月29日 2014年10月29日澳門 030830 北大維信 2008年1月29日 2015年1月29日 Xuezhikang 澳大利亞歐洲共同體格魯吉亞冰島挪威土耳其韓國日本 897114 北大維信 2006年8月15日 2016年8月15日 Xuezhikang 新加坡 T00/11607J 北大維信 2000年7月6日 2020年7月6日韓國 40-0904842 北大維信 2012年2月15日 2022年2月15日 WPU 韓國 40-0904849 北大維信 2012年2月15日 2022年2月15日 XZK 韓國 40-0904847 北大維信 2012年2月15日 2022年2月15日㹶㜸ᓭ 韓國 40-0904793 北大維信 2012年2月15日 2022年2月15日 ཝ㔪韓國 40-0904837 北大維信 2012年2月15日 2022年2月15日 CMNa VI-3

附錄六知識產權商標註冊地註冊號註冊擁有人有效期 Xuezhikang 韓國 40-0904816 北大維信 2012年2月15日 2022年2月15日 Lipocare 澳大利亞 1104649 北大維信 2011年8月17日 2021年8月17日 Lipocare 韓國 1104649 北大維信 2013年2月8日 2023年2月8日 Lipocare 新加坡 1104649 北大維信 2011年8月17日 2021年8月17日 Lipocare 日本 1104649 北大維信 2011年8月17日 2021年8月17日於中國待審批的商標申請截至最後實際可行日期我們已於中國申請註冊下列我們認為對業務重要或可能屬重要的商標商標申請編號類別申請人申請日期 12124007 35 山東綠葉 2013年1月31日 12124008 35 山東綠葉 2013年1月31日 9997379 5 山東綠葉 2011年9月23日 13384261 5 山東綠葉 2013年10月18日 12853695 5 山東綠葉 2013年7月3日 13236666 5 南京綠葉思科 2013年9月13日 12039803 35 四川綠葉 2013年1月14日於中國境外待審批的商標申請截至最後實際可行日期我們已於中國境外申請註冊下列我們認為對業務重要或可能屬重要的商標商標註冊地申請編號申請人申請日期越南 1033791 山東綠葉 2009年11月10日巴基斯坦 275539 山東綠葉 2009年12月8日印度尼西亞 D002013028018 山東綠葉 2013年6月12日 VI-4

5,6,7,8 6-[n,n[(2 ]] 1 5 ZL201210239917.8 2012711 2032710 ZL201310081158.1 2013314 2033313 ZL201210277120.7 201286 203285 ZL200510109980.X 2005921 2025920 ZL03136127.7 2003515 2023514 ZL99103226.8 1999329 2019328 ZL01119952.0 200173 202172 ZL201110004370.9 2011111 2031110 ZL200910149941.0 2009616 2029615 ZL200910167125.2 2009820 2029819 ZL200610073308.4 200647 202646 ZL99815996.4 19991230 20191229 VI-5

ZL02113591.6 2002410 202249 ZL03151291.7 2003929 2023928 4 4-[2 1-1 ] ZL201180036015.8 2011928 2031927 ZL01141431.6 2001925 2021924 ZL200510007230.1 200525 202524 ZL200410086151.X 20041027 20241026 ZL200610081116.8 2001925 2021924 ZL200610099050.5 2006717 2026716 ZL97103970.4 199749 201748 ZL200610145837.0 20061117 20261116 ZL200610145838.5 20061117 20261116 ZL97116744.3 1997813 2017812 ZL200810118908.7 2008826 2028825 ZL200910085113.5 2009531 2029530 ZL200910085110.1 2009531 2029530 ZL200710099833.8 2007531 2027530 ZL00119039.3 20001019 20201018 ZL 00119038.5 20001019 20201018 VI-6

ZL03112908.0 200334 202333 ZL200410014200.9 200432 201431 US6475520 19991230 20191229 5 US6271250 200046 202045 JP4598227 200047 202046 EP1043316 200045 202044 US8178724 US8487132 2006616 2028126 PTA 1 905 2006616 2026615 CA2309100 1998116 2018115 US6632428 200044 202043 US6046022 1997116 2017115 US7238348 2003128 2024527 PTA 1 486 SG72467 1998116 2018115 KR10-0683233 1998116 2018115 HK1108656 2008312 2028311 VI-7

HK1108655 2008312 2028311 HK1017614 1997813 2017812 HK1108696 2008312 2028311 HK1126982 2009717 2029716 HK1126141 2009526 2029525 EP1044009 1998116 2018115 US7091336 2001228 2021414 PTA 1 46 RU2303978 ID0017474 IN193666 IN206223 2001228 2021228 2001228 2021227 RU2264808 2001228 2021228 RU2264807 2 2001228 2021228 ID P0025604 2001228 2021227 IN205351 2 IN208865 2 EP1332755 2 JP4890732 2 2001228 2021227 2001228 2021227 2001228 2021227 2001228 2021227 1 PTA 2 20108 VI-8

CN201280006994.7 2012410 CN201110332409.X 20111028 4 4 [2 CN201310462622.1 2011928 1 1 ] (2 4 4 [2 CN201310464696.9 2011928 1 1 ] (2 CN201310136505.6 2013418 CN201310605917.X 20131126 4 (2 CN201310643492.1 2013123 1 CN200910088525.4 200979 CN201010291565.1 2010926 HMG-CoA CN201010270536.7 201091 CN201010270529.7 201091 VI-9

CN201210023584.5 201222 CN201210163327.1 2012523 CN201110442009.4 20111226 CN201210107485.5 2012413 CN201210107172.X 2012412 CN201210394958.4 20121017 US11/663,411 2005921 4 4 [2 US13/846,773 2011928 1 ] US13/989,550 20111125 US14/113.738 2012410 567 8 US14/128,131 2012621 VI-10

luye.cn 2003318 2023318 luye.com Shandong Langhe 200968 202368 Biotech Co. Ltd. luye-pharm.com 1999810 2016810 kanghaipharm.com 20031212 20151212 luyesike.com 2010622 2015621 luyesike.cn 2010622 2015621 luyebg.com 20111219 20161218 wpu.com.cn 1998326 2015326 VI-11

(1) eipo (2)...201472 1130 (3)...201472 1145...201472 12 eipo...201472 12 (4)...201472 12...201472 12 (5)...201472.................201